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Abstract
Clostridium histolyticum secretes collagenases ColG and ColH to cause extensive tissue
destruction during myonecrosis. The collagenases are multi-domain enzymes consisting of a Nterminal collagenase module, s1, polycystic kidney disease (PKD)-like domains (s2 in ColG; s2a
and s2b in ColH) and collagen-binding domains (CBD) (s3a and s3b in ColG; s3 in ColH). The
individual CBD and PKD-like domains chelate calcium to modulate stability and domain
rearrangement. Though used by bacteria to break down collagen in the extracellular matrix
during infection, therapeutic use of the enzyme to break down excess connective tissue has been
approved by the FDA. Meanwhile, the use of the targeting segment to anchor therapeutics at the
lesion site is currently underway. To better understand both the mechanism of collagenase during
infection and facilitate its use in drug delivery, the high-resolution structures of the PKD-like
domains and CBD of collagenases ColG and ColH were solved using X-ray crystallography. The
structures of Ca2+-absent (apo)-s2 and s2a, as well as Ca2+-bound (holo)-s2a, s2b, s3a-s3b, and
s3 are new structures, while the structure of holo-s3b was re-refined at higher resolution.
Individually, the structures of the CBD are similar and share conserved Ca2+ and collagenbinding pockets. In the tandem CBD, s3a-s3b, the domains are related by a pseudo two-fold
symmetry that may allow tandem CBD to bind to separate collagen molecules. Furthermore,
three aromatic residues that were identified to be crucial to collagen-binding are fully conserved
in s3, but only partially conserved in s3a. Evolutionary pressure likely decreased collagen
affinity of s3a to prevent s3a-s3b from binding too tightly on the surface of collagen fibril.
Meanwhile, the structures of the PKD-like domains are similar, though surface exposed aromatic
residues are found only on the ColH PKD-like domains. Furthermore, the change in Cα B-factors
upon Ca2+-binding further suggests a divergence of function for ColH and ColG PKD-like

domains. In each case, Ca2+-binding further stabilized the robust domains against denaturants
heat, urea, and guanidium chloride. For s3a-s3b, the influence of Ca2+ was further explored using
small angle X-ray scattering, which indicates the linker between domains gradually contracts in
the presence of increasing Ca2+ concentrations.

©2017 by Ryan Bauer
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Chapter 1: Introduction
Collagen
In animals, procollagen chains containing Xaa-Yaa-Gly repeats, where Xaa and Yaa are
frequently proline and hydroxyproline respectively, can assemble into triple helical
tropocollagen. Mammalian heat shock protein 47 (HSP47) is a collagen specific chaperone that
associates with procollagen and assists with folding into tropocollagen (1). In the fibrillar
collagens, this tropocollagen further assembles into microfibrils and fibrils that provide the
structural support to tissues such as skin and bone. Overall, the different types of collagen can be
grouped into subfamilies based on their supramolecular structure: fibril forming types I, II, III,
V, and XI collagens; network forming types IV, VIII, and X collagens; anchoring fibril type VII
collagen, transmembrane domain type XIII collagen, and FACIT type IX, XII, XIV, and XVI
collagens that interact with beaded filament forming type VI collagen (2). As part of the
processing into mature type I or type III collagen, non-helical flanking segments called
propeptides are proteolytically removed, though a small, non-helical segment called the
telopeptide is retained. The telopeptides are the location of intramolecular cross-links that help
stabilize the fibril and improve tensile strength (3). Three dimensional structural characterization
of collagen fibril and fiber is hindered by the size and heterogeneity of the molecule, though Xray fiber diffraction of type I collagen does suggest that the tropocollagen packs into a quasihexagonal arrangement that exposes the C-terminus of the molecules in the fibril (4, 5). The tight
packing of collagen in the fibril, as well as the triple helical confirmation of tropocollagen
shields peptide bonds from common proteases, such as trypsin. In response, specialized
collagenolytic proteases are have evolved to degrade collagen, either for remodeling of aged or
damaged collagen, or as part of bacterial infection. In mammals, a variety of matrix
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metalloproteinases (MMPs) are used to break down collagen as part of the tissue remodeling
process. Bacteria utilize collagenases, which can break down a wider variety of collagens and
digest the collagen into shorter fragments compared to the MMPs.
Comparison of MMPs and bacterial collagenases
Mammalian MMPs and the bacterial collagenases from Clostridium histolyticum, which
are discussed in this dissertation, are multidomain enzymes that utilize contrasting mechanisms
to degrade collagen. Likewise, the motif responsible for zinc binding is different. Bacterial
collagenases utilize the HEXXH motif, while MMPs utilize an elongated HEXXHXXGXXH
motif (6-9). The MMPs comprise a network of enzymes that each fill a specific role in
dismantling of collagen (6). While MMP-2 acts on the collagen triple helix, it can also hydrolyze
gelatin (denatured collagen) and therefore, is also considered a gelatinase (10). For type I
collagen, which is composed of two α1 chains and one α2 chain, the MMP cleaves the Gly775Ile776 bond in the αI chain and the Gly775-Leu776 bond of the α2 chain (6). Hydrolysis at this
site results in a ¾ length, N-terminal fragment called the TCA fragment and a ¼ length, Cterminal fragment called the TCB fragment. Conformational instability in these segments helps
further unwind the collagen helix. The resulting gelatin can then be processed by MMP2. MMPs
are multidomain enzymes that feature a catalytic domain that is connected to a four-blade βpropeller hemopexin domain. The zinc coordinating motif is found in the catalytic domain.
MMP is expressed as a zymogen called pro-MMP. Structures of pro-MMP-1 (PDB ID: 1SU3)
and active MMP-1 (2CLT) are available. Comparison of the two reveals the inhibitory
mechanism. In the pro-MMP-1 structure, the N-terminal inhibitory peptide not only blocks the
catalytic site using a cysteine-switch interaction with zinc (7), but also draws the domains
together by interacting with the C-D loop of blade 1 in the hemopexin domain (11, 12).

2

Comparison with active MMP-1 also indicates that cleaving the inhibitory peptide creates a
groove that forms the collagen binding site (11, 12). MMPs also feature “exosite” regions that
are believed to be responsible for not only substrate recognition (13), but also unwinding
collagen to allow only one chain in the catalytic site at a time (14). Analysis of the E219A
mutant of MMP-1 and collagenous peptide using hydrogen deuterium mass spectrometry
suggested that exosites were located on blades one and four of the hemopexin domain, while
mutagenesis identified Ile290 and Arg291 specifically as exosites (15). Further mutagenesis
studies identified Phe301 as the most vital residue in collagen binding (10). The crystal
structure, solved in the absence of collagen, suggest that this residue is buried within the
interface between the domains. Small angle X-ray scattering (SAXS) data, however, suggests
that transient movement of the domains exposes this residue (10).
Unlike the MMPs, each bacterial collagenase can rapidly hydrolyze multiple sites on
collagen (16, 17), and are utilized to destroy the host extracellular matrix during infection.
However, controlled applications of collagenases can be tailored to target therapeutics to their
active site, remove excess connective tissue, isolate cell cultures from the extracellular matrix,
and reduce environmental pollution during leather production (18). These collagenases comprise
peptidase families M9, S1, S8, and S53, and U32 of the MEROPS database (19). The M9
collagenases are zinc protease family and can be further divided into subfamilies M9A (secreted
by Vibrio) and M9B (secreted by Clostridium). All enzymes in this family share an N-terminal
catalytic unit. However, the remaining domain structure varies. In M9B, the C-terminus consists
of one to three domains that are called the collagen-binding domain (CBD), and carry out the
namesake non-covalent attachment of the enzyme to collagen. In between these domains are the
polycystic kidney disease (PKD)-like domain. The role of the domain is not well defined, though
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a potential division of roles in relationship to the number of CBD present is presented in chapter
4. Except for ColT, the collagenase secreted by C. tetani, which has no PKD-like domains, the
M9B collagenases contain one or two PKD-like domains. In M9A, the collagenases can be
further divided into class II and class III proteases (class I proteases belong to the M4 family
have no collagenolytic activity). Only the collagensase module is found in class II collagenases
(20, 21), while class III collagenases have a PKD-like domain and C-terminal domains, which
are classified as prepeptidase C-terminal domains, as it is currently not known if the domain is a
collagen-binder (22-24). The collagenase from Grimontia hollisae is closely associated with
M9A class III collagenase, though it does not have a PKD-like domain. The Grimontia genus
was originally classified as a member of the Vibrio genus (25), though in 2003, the bacterium
was reclassified as a member of Grimontia (26). To date, no structural knowledge for the
domains of M9A collagenase exists. The enzyme has commercial interest as its specific activity
is four times greater than that of C. histolyticum (27). Like the class III collagenases, the enzyme
from Grimontia can degrade soluble and insoluble collagen, as well as the and Pz-PLGPR
peptide (28). Unlike these class III enzymes, the enzyme cannot degrade casein (27). To date, no
structure of the M9A collagenase domains is available.
The current structural knowledge of bacterial collagenases comes from ColG and ColH,
which are secreted by C. histolyticum. As noted above, each contains a collagenase module,
called s1, though ColG has one PKD-like domain, s2, and two CBDs, s3a and s3b, while ColH
has two PKD-like domains, s2a and s2b, and only one CBD, s3. The first domain to be solved
was ColG-s3b (29), which was solved both in the presence of calcium ions (PDB ID 1NQD), and
in the absence of calcium ions (PDB ID: 1NQJ). In each condition, the overall structure has a βjelly roll conformation. The CBD each bind to two Ca2+, while the PKD-like domains bind to
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one Ca2+. Ca2+-binding stabilizes s3b against denaturants (30) and is shown to stabilize s3 and
the PKD-like domains in chapters two and three respectively. In chapter four, the role of Ca2+ in
triggering domain rearrangement in s3a-s3b is shown and the potential implication for collagenbinding by the segment is discussed. Though these domains do not possess collagenolytic
activity, they make up the targeting segment of the collagenase and are necessary for the enzyme
to dismantle insoluble collagen. Beyond applications of collagenase to desired removal of excess
collagen, the targeting segments themselves are being evaluated as drug delivery vehicles. The
structure-based contribution of either individual CBD, s2b-s3, or s3a-s3b is discussed in chapters
two through four. Significant to the goal of targeted drug delivery, both collagen-binding and
therapeutic activity are retained in fusion proteins of the drug and collagen-targeting segment.
In 2011, the first structure of a collagenase module, from ColG, was solved (31). Three
structures were solved: apo (calcium and zinc absent) Se-Met substituted structure (PDB ID:
2Y3U), the zinc containing structure (2Y50), and the structure inhibited by isoamyl-phosphonyl
Gly-Pro-Ala (2Y6I). The s1 structure resembles a saddle composed of an N-terminal activator
domain and C-terminal catalytic domain connected by a nine residue linker (31). Within the
activator domain ten HEAT motifs are found. These motifs may facilitate in substrate
recognition, and may also help with catalytic turnover after hydrolysis. The overall domain is
necessary to hydrolyze soluble collagen, though the catalytic domain itself is the minimal
gelatinolytic segment (31).
Given that the bacterial collagenases can each hydrolyze collagen fibril into small
peptides, it would initially seem odd that C. histolyticum would invest in carrying two
collagenases in its genome. Utilizing two collagenases, however, facilitates the bacterium’s goal
to expose new nutrient sources in the host before the host immune system can respond. ColG and
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ColH have been shown to work synergistically to degrade collagen (32), in part by initially
acting on separate regions (17). Though the technique has not been applied to ColH, high-speed
atomic force microscopy has been used to observe collagen fibril digestion by ColG in real time
(33). ColG was initially observed anchoring onto disordered regions of the fibril and then
processively moving towards the N-terminus of the fibril. Curiously, trimmed collagen
molecules, during this movement were observed migrating onto and thickening neighboring
fibrils. The structure of s3a-s3b presented in chapter four may help to explain these phenomena.
Observation of rare cis-peptide bonds in proteins
The structures of s3b and s2a contain a unique bond rarely found in protein, the nonprolyl cis-peptide bond. The bond is extremely rare and energetically unfavorable, and thus,
tends to be conserved in highly restrained environments where it fulfills key structural and
functional roles (34). In s3b, the bond between N-terminal linker residues Glu901 and Asn902
isomerizes into the cis confirmation upon Ca2+ binding (29). While stabilized by the ions,
isomerization serves critical function to position s3a into the unique pseudo-two-fold
arrangement described in chapter four. The peptide bond, unlike the phi and psi bonds that also
make up a protein’s main chain, is rigid due to resonance-induced delocalization of electrons in
the carbonyl π bond and nitrogen lone pair. Consequently, the peptide bond torsion angle can be
characterized as either cis, where the Cα of the connected amino acids lie on the same face of the
peptide bond (Cα-N-C-Cα torsion angle close to 0°), or trans, where the Cα atoms lie on
opposite faces (torsion angle close to180°).
The isomerization barrier from trans to cis varies. Prolyl peptide bonds connect any
amino acid to proline (Xaa-Pro), while non-prolyl peptide bonds, the nitrogen comes from any
amino acid that is not proline. For non-prolyl peptide bonds, the trans confirmation is
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significantly favored as steric hindrance between Cα atoms in the cis confirmation is absent in
the trans confirmation. Due to this steric strain, non-prolyl cis-peptides are extremely rare. A
survey of 571 proteins revealed that only 0.03% of non-prolyl peptide bonds were in the cis
confirmation (35). For prolyl peptide bonds, steric strain is also found in the trans confirmation
since the Cδ essentially destabilizes the confirmation by taking the place of the Cα atom after
isomerization. The trans confirmation is still favored, however. In the above survey, 94.8% of
prolyl peptide bonds were found in the trans configuration (35). It is significant to note that in
the above survey, the resolution of the crystal structures studied was 2.0 Å and above. A recent
survey of non-prolyl cis-peptide bonds indicated that identified cis-peptide bonds were likely
erroneously placed in lower resolution structures (36). The lowest resolution structure of s3b is
1.65 Å, while the lowest resolution structure of s2a is 1.9 Å. Each structure is solved at
sufficiently high resolution to justify the observation of non-prolyl cis-peptides. Due to their
rareness and their implications for the structure and function of proteins, non-prolyl cis-peptides
have emerged as a topic for theoretical and modeling studies. The role of Ca2+ in catalyzing the
isomerization and stabilizing the subsequent non-prolyl cis-peptide bond in s3b has been studied
using a combination of quantum mechanics and molecular mechanics (37). The results showed
that the presence of two Ca2+ lowers the free energy barrier for isomerization by 11 kcal/mol and
helps to initiate a hydrogen bonding network that stabilizes the region. The non-prolyl cispeptide bond is not induced by Ca2+ binding in s2a, but its role in replacing proline to form a βbulge could facilitate modeling studies on how the bond influences protein folding.
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Chapter 2: Structural comparison of ColH and ColG collagen-binding domains from
Clostridium histolyticum
Abstract
Clostridium histolyticum secretes collagenases, ColG and ColH that cause extensive tissue
destruction in myonecrosis. The C-terminal collagen-binding domain (CBD) of collagenase is
required for insoluble collagen fibril binding and subsequent collagenolysis. The high resolution
crystal structures of ColG-CBD (s3b) and ColH-CBD (s3) are reported in this paper. The new
X-ray structure of s3 was solved at 2.0 Å resolution (R=17.4%, Rfree=23.3%), while the
resolution of the previously determined s3b was extended to 1.4 Å (R=17.9%, Rfree=21.0%).
Despite sharing only 30% sequence identity, the molecules resemble one another closely
(r.m.s.d. Cα = 1.5 Å). All but one residue whose sidechain chelates with Ca2+ are conserved.
The dual Ca2+ binding site in s3 is completed by an unconserved aspartate. Differential scanning
calorimetric measurements showed that s3 gains thermal stability, comparable to s3b, by binding
to Ca2+ (holo TM=94.1 °C, apo TM=70.2 °C). Holo s3 is also stabilized against chemical
denaturants, urea and guanidine HCl. The three most critical residues for collagen interaction in
s3b are conserved in s3. The general shape of the binding pocket is retained by altered loop
structures and side chain positions. Small angle X-ray scattering data revealed that s3 also binds
asymmetrically to mini-collagen. Besides the calcium-binding sites and the collagen-binding
pocket, architecturally important hydrophobic residues and hydrogen-bonding network around
the cis-peptide bond are well-conserved within metallopeptidase subfamily M9B. CBDs were
previously shown to bind to extracellular matrix of various tissues. Compactness and extreme
stability in physiological Ca2+ concentration possibly make both CBDs suitable for targeted
growth factor delivery.
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Introduction
Clostridium histolyticum is one of the causative agents for clostridial myonecrosis. The
organism produces collagenases responsible for extensive tissue destruction. Although
collagenases are harmful during infection, their ability to break down a wide variety of collagen
types make them beneficial as a treatment for excessive connective tissue build up. The enzymes
are approved by the Food and Drug Administration (FDA) to break down the tough cords in
Dupuytren’s contracture (38). The two classes of collagenase, ColG and ColH, differ in domain
structures (s1, s2, s3a, s3b for ColG; and s1, s2a, s2b, s3 for ColH). The s1 is the collagenase
module that belongs to a metallopeptidase M9 subfamily B (M9B) of bacterial collagenases. The
structure of ColG-s1 was recently solved, and revealed an overall saddle shape built up by an
activator domain linked to a peptidase domain (31). The amino acid sequences of s2, s2a and
s2b resemble a polycystic kidney disease domain. The role of this domain is speculative. It was
shown that the PKD-like domain of the serine protease from Pseudoalteromonas sp. SM9913
could bind to and swell collagen microfibrils (39). The PKD-like domain has also been shown to
enhance collagen binding (40). The C-terminal domains, s3a, s3b and s3 (swissprot: Q46085,
pubmed: BAA34542) are homologues with approximately 120 amino acid residues, and are
classified as bacterial pre-peptidase C-terminal domains (PPC super-family). The PPC domain is
found in some members of metalloprotease families M4, M9 and M28 as well as in a serine
protease family S8. In silico work on the PPC domain suggests a distant relationship with the
PKD-like domain (41). Moreover, the role of the PPC domain could be diverse. Some of the
domains are removed after secretion for certain protease activation (41), but others are retained
in the mature enzymes (42). Both ColG-derived s3a-s3b and ColH-derived s3 bind to either
insoluble collagen in vitro or to collagen fibrils in the extracellular matrix of various tissues (43,

9

44). Therefore, each of these PPC domains is sub-classified as a collagen-binding domain
(CBD).
CBD derived from ColG (s3b) has been extensively characterized. It is a β-sandwich
fold, and a pocket formed on a β-sheet was identified to interact with the substrates by alaninescan mutagenesis and mini-collagen binding assays (29). The s3b binds to collagenous peptides
with triple helical conformation but not to the similar peptides lacking triple helical conformation
or to gelatin (denatured collagen), suggesting that the CBD-collagen interaction is conformationspecific (40, 43). The most recent solution studies of s3b in complex with collagenous peptides
by small angle X-ray scattering (SAXS), and heteronuclear single quantum coherence (HSQC)
NMR titration of various spin-labeled collagenous peptides to

15

N-labeled s3b showed that s3b

binds unidirectionally to the C-terminus of collagenous peptides (45).
In the presence of Ca2+, s3b shows shortened hydrodynamic radius, better stability and
more efficient substrate binding (29). The X-ray crystal structures of s3b were solved in the
presence of Ca2+ (holo) as well as, in the absence of Ca2+ (apo) to show a secondary structure
transformation of the linker at its N-terminus (29). The linker is coiled as an α-helix in the apo
form, but is unwound to form a parallel β-strand in the holo form, which possibly resulting in
domain rearrangement. Two Ca2+ bind cooperatively with macroscopic association constants of
K1=5.01x105 M-1 and K2=2.28x105 M-1 to trigger the structural transformation (30). Two Ca2+
ions chelate to s3b in close proximity to each other (3.7Å). The N-terminal linker of s3b adopts
an energetically unfavorable non-prolyl-cis-peptide in the presence of Ca2+. Simulations
provided mechanical insights of calcium ions catalyzing the trans-cis isomerization of the nonprolyl peptide bond (37). Previously, it was shown that ColG-s1 does not require the PKD-like
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domain or CBDs to degrade gelatin (40) or soluble collagen (31). These domains, however, are
necessary to degrade collagen fibrils.
The s3 from ColH has been shown to anchor growth factors to extracellular matrix, and
extend their half-lives. A fusion protein of basic fibroblast growth factor and s3 domain stayed at
the site of injection for more than 10 days to promote cell proliferation (46). Although various
preclinical applications are currently being examined (46-50), s3 has not been characterized in
detail. The s3 and s3b share 30% sequence identity. Only three aromatic residues within nine
residues in s3b involved in the substrate binding are conserved in s3. Based on the sequence
alignment, one of the Ca2+-chelating aspartates (Asp927) in s3b is replaced by serine (Ser896) in
s3 (Note that in this manuscript, the sequence number for each CBD refers to the mature protein:
the s3b sequence numbering reflects a 110-residue long secretion tag being cleaved, while s3
numbering reflects a 40-residue long tag being cleaved). Each of the two sidechain oxygen atoms
of Asp927 chelates with a different Ca2+ ion. It was uncertain as to how Ser896 in s3 could
construct the dual calcium-binding site in place of the bidentate Asp. To address its structure and
function relationship applicable for various drug delivery applications (46-50), structural work
on s3 was initiated. The structures of dissimilar CBD molecules in metallopeptidase family
M9B enabled us to compare and contrast their Ca2+ sites and collagen-binding mechanism.
Methods
Expression and purification of collagen-binding domain
Expression and purification of collagen-binding domain as a glutathione S-transferase
(GST) fusion protein was achieved using methods described by Matsushita (43).
Crystallization and Structure Determination of s3 from ColH
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Recombinant s3 (7.0 mg/mL in 10 mM Tris-HCl pH 7.5) crystals were grown by hanging
drop vapor diffusion from 28% (w/v) PEG3350, 0.1 M Li2SO4 0.1 M Tris-HCl (pH 6.5), and 2
mM CaCl2. The crystals were subsequently flash frozen in liquid nitrogen without the need of
additional cyroprotectant and stored in liquid nitrogen until data collection. In house X-ray
diffraction facility (Rigaku 007, Osmic Blue confocal mirrors, Saturn CCD detector) was used to
characterize the unit cell parameters for s3. The calcium bound s3 crystals belong to the
orthorhombic space group P212121, with unit cell size a=62.0, b=66.2, and c=96.4 Å. The data
were collected at -164°C and diffracted to 2.6 Å resolution. Single crystal diffraction data were
then collected at the 19-ID beam line at the Advanced Photon Source at Argonne National
Laboratories. The crystals diffracted to 2.0 Å resolution. Data were processed using HKL3000.
Molecular replacement technique using PHASER on a data set truncated to 3 Å resolution
located three molecules in an asymmetric unit (51). The Fo-Fc difference map clearly showed two
calcium atoms that were omitted from the search model, and increased confidence in the phase
information. Where possible, amino acid residues of molecule A were corrected to those of s3.
Using the partially built molecule A as a search model, molecular replacement techniques were
repeated yielding phases that allowed for building the complete s3. The models were refined
using REFMAC to 2.0 Å resolution (52). In the strong difference map peaks (Fo-Fc with σ>3.5
and 2Fo-Fc with σ>1.0), 326 solvent molecules were built. NCS restraints were not used during
the refinement. PROCHECK was used to ensure the stereo-chemical quality of the protein. Data
collection and refinement statistics are summarized in Table 1.
Crystallization and structure refinement of s3b from ColG
Recombinant s3b (5.5 mg/mL in 50 mM Tris-HCl pH 7.5) crystals were grown by
hanging drop vapor diffusion from 25-27% PEG 3350, 100 mM sodium acetate pH 4.6 and 600
12

mM LiCl at 4°C. As it is known to exist in two structural forms, the s3b was supplemented with
Ca(NO3)2 to a concentration of 50 mM in order to push the equilibrium towards the ion-bound
form (29). Crystals were dragged through 100% paraffin oil to remove excess solvent, and then
frozen in liquid nitrogen. The initial conditions suitable to grow s3b crystals were identified by
the sitting drop method using high throughput screen (Hampton Research Crystal Screen HT).
Cryo-protection procedures resulted in a low mosaic spread, 0.46°, and extended our data to 1.35
Å (unique reflections = 44,856) versus 1.65 Å resolution (unique reflections = 27,154) for our
previously deposited structure (29). The data were collected at BioCARS 14ID-B at Advanced
Photon Source. All the data were indexed and scaled using Denzo and Scalepack from HKL2000
(53). SHELX97(54) and REFMAC (52) was used for refinement (Table 1). The holo structure
(PDB code 1NQD) was used as a starting model. The manual adjustments were aided by the use
of MIFit (55). Seven alternate confirmations for surface residues (919, 959, 968, and 976 of
molecule A, 895, 968, and 976 of molecule B) were built. The positional and anisotropic Bfactor refinements were carried out using initially Shelxl97(54) then REFMAC (52). Hydrogen
atom positions were constrained to the ideal position during the refinement. However neither
non-crystallographic symmetry (NCS) restraints nor Ca…O bond restraints were applied.
Positional refinement, manual adjustments, and anisotropic B factor refinement resulted in an
R=17.9%, Rfree=21.0% (Table 1). The anisotropic temperature refinement is justified because
Rfree dropped nearly 5%. Seventy percent of all atoms including water molecules are very well
ordered (B-factor below 30 Å2), and their positional errors are less than 0.05Å.
Small Angle X-ray Scattering Experiments
The SAXS data were collected on solutions of s3, various collagenous peptides, and the
CBD-collagenous peptide complexes (between 4 and 6 mg/mL) in 10 mM Tris-HCl (pH 7.5)
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containing 100 mM NaCl and 20 mM CaCl2 at the XOR beamline of sector 12-ID at the
Advanced Photon Source (APS) in the Argonne National Laboratory. The main advantage of Xray scattering is that it can be carried out in solution in nearly physiological conditions (13). The
monochromatic radiation source (10keV, λ=1.2398 Å) was the APS Undulator A insertion
device using a Si-111 monochromator, with 1:1 horizontal focusing and higher harmonic
rejection from a Rh coated mirror, and beam defining slits set at 0.3 mm vertical and 0.25 mm
horizontal. A 1.6 mm diameter capillary flow-cell with a flow rate of 4 μL/second was used to
capture four frames with exposure time of 10 seconds. The SAXS detector used was a Mar165
scintillator fiber-optic coupled CCD detector and covered the momentum transfer range
0.005<q<0.198 Å−1, where q = 4π sinθ/λ (2θ is the scattering angle). The WAXS detector was a
custom made Roper scintillator fiber-optic coupled CCD detector and covered 0.191<q<1.8 Å−1
S (56).
All scattering data were acquired at 10ºC. The four scattering patterns from each detector
were averaged and merged with the rejection of outlying scans. For further analysis the program
IGOR Pro 5.5A (WaveMetrics) was used. The scattering profiles of the protein, peptide and their
complexes were obtained after subtracting the buffer profiles. The reduced scattering data were
plotted as scattering intensity I(Q) vs. Q (Supplementary Fig. 1A). The radius of gyration, Rg,
was obtained from the Guinier approximation by linear least squares fitting in the QRg < 1
region, where the forward scattering intensity I(0) is proportional to the molecular weight of the
protein complex. An indirect Fourier transformation of the I(Q) data, using GNOM (57),
provided the pair-distance distribution function P(r) in the real space. Where P(r) intersects with
x-axis represents the maximum diameter, Dmax (Supplementary Fig. 1B and table 2). The
molecular envelopes were constructed from the SAXS data after ab initio calculation with the
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program GASBOR (58). The P(r) ranges were varied to generate various (>10) molecular
envelopes using GASBOR (58). No symmetry restraints were applied to any of the shape
reconstructions. The ten highest scoring ab initio models were chosen and averaged using
DAMAVER (59). Atomic models were docked into ab initio envelopes with the program
SUBCOMB (60). The theoretical scattering curves from the atomic models were calculated and
compared with the experimental curves with the program CRYSOL (61). Rigid-body modeling
to the experimental scattering data was performed using SASREF (62).
Docking Model
The mini-collagen:CBD complex was generated from the CBD and 1K6F for the
collagenous peptide. To obtain the complex, the soft docking algorithm BiGGER was used (63).
The manual adjustments were aided by the use of MIFit (55).
Fluorescence Spectroscopy Measured Equilibrium Denaturation of s3
For s3, λmax for the native protein occurs at 310 nm while λmax for the denatured protein
occurs at 350 nm. The ratio of intensity at 350 nm versus the intensity at 310 nm was used to
track the unfolding process. Fluorescence data were collected on a Hitachi F-2500 fluorimeter
with excitation and emission bandwidths at 2.5 nm and 10 nm, respectively. The excitation
wavelength used was 280 nm, and fluorescence emissions were monitored between 300 nm and
450 nm. During thermal denaturation trials, temperature of the protein solution was maintained
with a Neslab RTE-110 circulating water bath (Thermo Scientific, Newington, NH, USA). In the
thermal denaturation trials, the protein concentration was 3µM. While in the chemical
denaturation trials, the protein concentration was 1.5 µM. Holo-s3 was supplemented with 1 mM
CaCl2, while apo-s3 was supplemented with 1 mM EDTA. In all cases, the protein was diluted
in 10 mM Tris-HCl and 100 mM NaCl, and the pH was maintained at 7.5. When urea was used
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as the denaturant, the native s3 was exposed to concentrations of denaturant that increased
linearly by 0.2 M intervals from 0.0 to 9.8 M. When guanidine hydrochloride (GuHCl) was used
as the denaturant, the s3 was exposed to concentrations of denaturant that increased linearly by
0.2 M intervals from 0.0 to 5.8 M. During thermal denaturation, the s3 was exposed to
temperatures that linearly elevated by 2.5°C intervals from 7.5 to 100°C. GH2O and m values
were calculated as described (30).
Differential Scanning Calorimetry
DSC was conducted using a Nano-Differential Scanning Calorimeter (NDSC) model
CSC 6300 (Calorimetry Sciences Corporation). The s3 was dissolved in 10 mM Tris-HCl (pH
7.5), and 1 mM CaCl2 for the holo form to a final concentration of 0.5 mg/mL. The apo-s3 was
dissolved in 10 mM Tris-HCl (pH 7.5) to a final concentration of 0.5 mg/mL. Following a scan
of buffer vs. buffer to establish the baseline, samples were run as follows. Degassed samples
were heated from 25°C to 130°C (1°C/min) and then cooled back to the initial temperature at the
same rate. A second heating scan was then performed to test the reversibility of the process.
Unfolding was reversible if a difference in heat capacity was again observed during the second
heating scan. DSC analysis software (CpCacl1) provided by the instrument manufacturer was
used to analyze the transition temperature after subtracting the baseline.
Results and Discussion
Structure Description of s3 at 2.0 Å Resolution
The structure of s3 from ColH is similar to the structure of s3b from ColG. The s3 also
adopts a β-sandwich ‘jelly-roll’ conformation composed of nine β-strands. Two calcium atoms
per molecule are found between the linker (861-878) and the β-strand C. There are three
molecules in the asymmetric unit. Molecule A consists of 117 amino acids (863-979), molecule
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B consists of 120 amino acids (862-981) and molecule C consists of 121 amino acids (861-981).
The backbone structures of the three molecules (A-C) are virtually identical. The root mean
square deviations of C positions between molecules A and B, determined using Superpose from
the CCP4 suite of programs, was 0.29 Å, that between B and C was 0.45 Å, and that between A
and C was 0.43 Å. Three molecules were independently refined without NCS restraints. Inherent
flexibility was observed at both the N-terminus (861-863) and C-terminus (977-981). Another
deviation occurs only in molecule C at the loop between β-strands H and I (966-969) caused by a
peptide flip between Ser967 and Tyr968. Both calcium atoms are ordered (B-factor < 18 Å2).
Structural Comparison of holo s3b and holo s3
Here we present the first structure of a domain from ColH collagenase. The tertiary
structures of the CBD molecules are very similar to one another (Cα r.m.s.d = 1.4 Å), despite
being of low sequence identity. β-Sheet regions are the most similar. Even the linker residues
898-910 of s3b and 867-879 of s3 adopt very similar structure. The Ser874–Thr877 segment of
s3 adopts a short 310 helix as also observed in the Ser905-Lys908 segment of s3b. In both
structures two calcium ions bind between the N-terminal linker and the β-strand C. The s3 does
not adopt β-strand A found in s3b, and the region adopts a random coil. Also, the solution
structure of apo-s3b does not form β-strand A(64). The crystal structures of s3 and s3b are most
divergent at the N-terminus and loops connecting the β-strands. For example a loop of 8 residues
(Glu961-Ile968) between β-strands E and F in s3b are line broadened and non-assignable on
NMR and the flexible loop is unobserved in the crystal structure (29, 45). In contrast, the
equivalent loop in s3 (Glu930-Val935) is well ordered. Another significant deviation in loop
structures occurred at a loop between strands B and C (924-928 in s3b; 894-899 in s3). The Ntermini of s3b (891-897) and s3 (861-868) adopt very different paths. It is possible that this
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deviation can be explained by crystal packing restraining the position of the termini. Termini
deviation as a result of crystal packing for example, was seen in the N-terminal linker of apo-s3b
(29, 64).
Coordinations around the two calcium atoms in s3 are virtually identical to those
described in detail for s3b later. Seven oxygen atoms of five side chains and one main-chain
form pentagonal-bipyramid coordination (Fig. 1). Eight oxygen atoms of four side chains and a
main-chain and one water form square antiprismatic coordination. The average bond distances
observed in s3 are similar to those in s3b (Supplementary Tables 2 and 3). There are some
differences between the two CBD molecules. Asp904 in s3b is replaced by Asn873 in s3; and
therefore the net charge around the calcium sites in s3 is -4. Earlier sequence alignment of CBD
molecules showed that Asp927 in s3b is replaced by Ser896 in s3 (29). However, serine is rarely
found to chelate with Ca2+ (65). The crystal structure of s3 revealed that Asp897 is found in
place to chelate with Ca2+ atoms and Ser896 is pointed away from the ions. In order for Asp897
to chelate equivalently to Asp927 of s3b, a loop (894-898) of s3 meanders differently to position
OD1 and OD2 atoms of Asp897. Two energetically unfavorable torsional strains were found in
s3b (29). One of them is the peptide bond between residues Glu901 and Asn902 in s3b that
adopts an uncommon and energetically unfavorable non-prolyl-cis-peptide conformation. OD1
of Asn902 makes a hydrogen-bond with main-chain N of Asp904. The interaction is one of the
important hydrogen-bonds in the stabilization of the transition state for the peptide isomerization
(37). In contrast, the structurally equivalent peptide bond between Glu870 and Pro871 in s3
adopts a common prolyl-cis-peptide conformation (Fig. 2). The second torsional strain was
found in the side chain 1 angle of residue Tyr931 of s3b. Tyr931 adopts an energetically
unfavorable angle of 64, which is stabilized by hydrogen- bonding with NE2 of His959 of s3b
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(distance = 2.6 Å). The equivalent residue Tyr900 of s3 adopts a favorable 1 angle of -68 (Fig.
3). The s3b is extremely thermostable (TM=93C) despite the torsional strains (30). The s3 is
only slightly more stable (TM=94°C). The stability of s3 is described in more detail in the
following section.
The collagen-binding surface in s3b was identified by binding assay of 32 surface
mutants (29) and by HSQC-NMR titration (45). Three aromatic side chains critically involved in
collagen-binding are positioned similarly in s3. Two tyrosine residues (Tyr970 and Tyr994) in
the s3b are conserved in s3 (Tyr937 and Tyr962), but Tyr996 is replaced by phenylalanine
(Phe964) in the s3. Seven other residues identified to interact with the collagenous peptides are
not conserved in s3. SAXS and NMR studies of s3b in complex with collagenous peptides
showed that Ser928 and Arg929 interact with the C-terminus of collagenous peptide (45).
Neither residue is conserved in s3. In s3, main-chain carbonyl Thr895 occupies where Ser928
side chain is found, and the three-dimensional space occupied by Arg929 in s3b is occupied by
Gln898 and Tyr900 in s3 (Supplementary Fig. 2). Despite substitutions, the resulting collagenbinding pocket in s3 closely resembles that of the s3b. Using SAXS of s3 in complex with
[G(POG)7PRG]3 showed that s3 also binds asymmetrically to the collagenous peptide (Fig. 4).
Our previous work demonstrated that both (POG)10 (hydroxylproline is represented as O) and
G(POG)7PRG adopt a triple helical structure in solution. They are thus represented as [(POG)10]3
and [G(POG)7PRG]3, respectively. The resulting atomic models for s3 and s3b fit very well into
the ab initio SAXS envelopes. The theoretical Rg values calculated from the complex models of
s3 and s3b are in excellent agreement with the experimental values (Table-2). The theoretical
scattering curves calculated from the models using CRYSOL (61) are superimposable with the
experimental curves with minimal discrepancy (Table-2).
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Rigid body modeling to the

experimental scattering data was performed using SASREF (62). Collagenous complexes with
either s3 or s3b were fitted independently to the X-ray scattering data. The simulations were
repeated 10 times. The model with the lowest value is shown (Fig. 3 and Supplementary Fig 3).
S3b binds asymmetrically to the C-terminal (POG)3 repeats or C-terminal (POG)2PRG (45).
Since critical aromatic residues are oriented similarly in both structures, it is likely that s3 also
targets the C-terminal region. The respective collagenase could target common structural features
in collagen fibril. C-terminal region of collagenous peptide is slightly untwisted (under-twisted).
Our studies on s3b and s3 imply that the cleft-like shape of the binding pocket scans the collagen
for under-twisted regions and conserved aromatic residues of the pocket intercalate to the triplehelical collagen (66).
Ca2+ Coordination of s3b at 1.4 Å Resolution
The 1.4 Å resolution structure of the Ca2+ bound s3b showed excellent electron density
for nearly all protein atoms and water molecules. The protein is crystallized as a noncrystallographic symmetry (NCS) related dimer. Since the structural features have already been
described for s3b, the discussion will focus on calcium binding sites. Calcium associates with
s3b in two coordination geometries, pentagonal bi-pyramidal and square antiprismatic (Fig. 1).
Both calcium atoms were highly ordered (B-factor <14 Å2). The pentagonal bi-pyramidal
coordination is commonly observed in calcium chelating proteins, of which calmodulin’s EF
hand motif is the classic example. Five ligating atoms encircle the calcium ion as a near-planar
pentagon and two remaining ligands sit at axial positions above and below. As in the ligation
pattern of EF hands, both carbonyl oxygen atoms of s3b’s Glu901 provide two of the five
equatorial ligation positions.

The atoms describing the equatorial plane have an average

deviation from planarity of 0.16 Å (Supplementary Table 2), which compares favorably to the
20

0.18 Å average deviations across calcium sites in calmodulin (PDB code 1OSA) (67). While
calmodulin has a water molecule occupying one axial position, allowing for greater flexibility in
ligand position, both axial positions in s3b are supplied by amino acid side chains (Asn903,
Asp927).
The s3b’s second calcium site with square antiprismatic coordination sits 3.7Å from the
pentagonal bi-pyramidal site. The planar faces of calcium-bound s3b’s square antiprism deviate
only slightly from flat geometry (Supplementary Table 3). One face shows an average out of
plane deviation by a mere 0.03 Å for coordinated atoms, while the other face shows only 0.13 Å
deviations.

These values vary from few other available protein structures with square

antiprismatic bound ions (Supplementary Table 4). Square antiprismatic coordination is
relatively uncommon among macromolecules (65), and few are currently found in the Protein
Databank. Ding et al., described a Zn2+ bound ribonuclease T1, at 1.8 Å resolution, in which six
water molecules and a sole aspartate coordinate zinc (68). When defined as square antiprismatic,
the carbonyl oxygen atoms of aspartate provide a ligand for each square face, creating significant
distortions from planar geometry for these faces and a very short ion-to-plane distance. On
further examination, the ion coordination in ribonuclease T1 is best described as trigonal
dodecahedral, rather than square antiprismatic, which explains the high deviations from
planarity. Potassium ions are found in square antiprismatic coordination in two structures, the
KcsA potassium channel and an Oxytricha nova G-quadruplex (69, 70). Main chain carbonyl
oxygens coordinate the KcsA potassium ions within the channel, and due to the four-fold
crystallographic symmetry, the square faces are perfectly flat. In the G-quadruplex structure, an
unusual DNA structure found in telomeric DNA, potassium ions sit similarly in the center of a
channel created this time by nucleotides. Thymine base O6 atoms coordinate the potassium and
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provide near-planar square faces, with two cubic coordinations sandwiching a square
antiprismatic coordination (Supplementary Table 4).
In addition to the CBDs, two calcium-binding proteins that utilize square antiprismatic
geometry are found in the literature.

Thermitase, an extracellular serine proteinase, when

crystallized in 100 mM calcium revealed a square antiprismatic calcium site in addition to two
pentagonal bipyramidal sites. At lower calcium concentrations the site exhibits pentagonal
bipyramidal coordination (71). Secondly, alpha-amylase binds two calcium ions with CN=8 (72).
One of these sites follows a square antiprismatic geometry with three water molecules acting as
ligands, and the deviations from planarity are near that of the thermitase coordination
(Supplementary Table 4). However, not all binding sites with CN=8 have square antiprismatic
geometry. The second site in alpha-amylase involves five waters and is best described as cubic.
Proteinase K binds to one calcium ion with CN=8 (73), but coordination is dodecahedral in
geometry. Four water molecules act as ligands.
The bidentate ligating nature of aspartates and glutamates, often found in ion
coordination, distort geometries from ideal, inorganic values. Therefore, square faces are rarely
square, with the exception of proteins taking advantage of multimerization as in KscA. Previous
publications showed that Ca2+ is involved in activation but not K+. However, Li+ was found in
the Ca2+ binding site (29). Barring occupancy differences, Ca2+ and K+ would have identical
electron density in an X-ray diffraction experiment. For the proteins shown in Supplementary
Table 4, the distance of calcium from the square faces formed in antiprisms averages 1.37 Å,
while potassium distances are a longer 1.58 Å. Additionally, the average ion-to-ligand distance
for calcium and potassium are 2.54 Å and 2.81 Å, respectively. The larger coordination radius
observed for potassium is not surprising since its ionic radius is greater than that of calcium.
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Based on the coordinate errors for oxygen atoms, the errors associated with the bond distances in
this study (Supplementary Table 4) are estimated to be less than 0.03 Å even accounting for 10%
underestimation (9). Based on the analyses of bond distances, it is clear that two Ca2+ bind to
s3b.
Another novel aspect of the dual calcium site is that it contains the rare tridentate acidic
side chains (Glu901 & Asp930). As far as we are aware, tridentate acidic side chain has never
been observed. Previous analysis of 1,605 Ca2+ binding sites showed that bidentate oxygen atoms
chelate with longer Ca2+-O distances than those found in monodentate (2.6 Å vs. 2.4 Å) (65).
Indeed, Ca2+-O in bidentate residues (Glu899 & Asp927) is longer than that in monodentate
(Asn903 & Asp904). We also note that the two bidentate residues chelate to Ca2+ differently.
Two carbonyl oxygen atoms of Glu899 side chain chelate with one Ca2+ atom where as two
carbonyl oxygen atoms of Asp927 chelate with two different Ca2+ atoms. Ca-O-C angles in
Glu899 (89°, 94°) are similar to the values observed for bidentate glutamates in other Ca2+
binding proteins (93.6±11.3°) (65), but the angles observed for Asp927 (131° and 144°) are
closer to angles observed in monodentate (140.4±15.2°) (65). In both tridentate residues (Glu901
& Asp930) one of the three bond distances is significantly shorter (<2.36 Å) than other two. CaO-C angles (87°, 96°, and 159°) are virtually identical for both tridentate residues. Electrostatic
repulsion between the cations is likely neutralized by the acidic residues. The coordination
geometry reported here could be useful in predicting proteins that utilize acidic residues to
chelate a cluster of divalent cations such as Ca2+, Mn2+, and Mg2+.
Stability Contributions of Calcium Binding
Both s3b and s3 are compact, and extremely stable in the presence of physiological Ca2+.
This may prolong enzyme activity against insoluble collagen in the extracellular matrix. Calcium
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bound holo-s3b was previously shown to be more stable than apo-s3b based on DSC and
fluorescence spectroscopy monitored equilibrium denaturation data (29, 30). Similar to the
observation in s3b, denaturation pathways obtained using either DSC (Fig. 5) or fluorescence
(Fig. 6) showed that holo-s3 is more stable than the apo-s3 (Supplementary Table 5). Stability
data were compared with those of s3b. DSC data showed that holo-s3 (TM= 94°C) was slightly
more stable than holo-s3b (TM= 93°C), though apo-s3 (TM= 70°C) was less stable than apo-s3b
(TM=74°C) (Supplementary Table 5). Whether, heat, urea, or guanidine hydrochloride (GuHCl)
was used to denature the protein, the same trends were observed. As a side note, the heat
denaturation was reversible for apo-s3 but not for holo-s3. Based on fluorescence monitored
thermal denaturation, neither holo-CBD fully unfolded at 100°C. Unfolding of s3 was monitored
using the fluorescence of intrinsic Trp925 that is sandwiched between β-sheets. Whereas
denaturation using urea or GuHCl on holo-s3 occurred as a cooperative transition from the native
to the denatured protein, the unfolding transition of apo-s3 is abrupt (Fig. 6). Apo-s3 begins to
unfold even at initial levels of chemical denaturant or heat. Meanwhile, the TM value for apo-s3
based on fluorescence data is significantly lower than that determined by DSC (Supplementary
Table 5). The discrepancy in TM was also observed in s3b (30). Analysis of holo-s3 structure
using NACCESS (74) demonstrated that Trp925 is solvent inaccessible. Also, crystal structures
of holo-s3b exhibited tighter packing around the Trp than apo-s3b (30). The folding studies
suggest that Trp in apo-s3 is much less tightly packed than apo-s3b.
As observed for s3b, a locally stable, solvent inaccessible core around Trp925 in holo-s3 could
explain the higher TM value observed using fluorescence data, while a locally unstable, solvent
accessible core around Trp925 in apo-s3 could explain the lower TM value observed using
fluorescence data.
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Evolutionary Related CBD
Both s3b and s3 molecules reported in this paper belong to the PPC super-family and are
collagen-binding domains (CBD). Common structural features described in the previous sections
enabled us to update the sequence alignment of the CBD in the M9B subfamily (Fig. 7).
Conserved residues are important for one of four reasons: calcium chelation (red), cis-trans
isomerization of the linker (yellow), collagen-binding (blue) or protein folding (green).
Conserved residues in unsolved CBD structures will likely fulfill roles found in s3 and s3b. The
dual calcium-binding site is formed by four chelating residues (Glu899, Glu901, Asn903, and
Asp904) within the N-terminal linker, two chelating residues (Asp927 and Asp930) from the βstrand C and invariant Tyr1002 hydrogen-bonds and orients Asp930. Residue numbers used in
this paragraph are of s3b. Likewise other supporting cast such as Gly921 is conserved in the
middle of β-strand strategically placed to make room for Glu899. The dual calcium chelation site
is fashioned sometimes by a neighboring residue. As mentioned, Asp897 of s3 acts equivalently
to Asp927 of s3b. Asp897 equivalents are tentatively identified in B. brevis s3a and s3b, C.
botulinum A3 s3a and C. histolyticum ColG s3a. Tridentate and divalent Asp and Glu residues
are conserved with only C. sordellii s3a as the exception. The monodentate Asp904 residue is
sometimes substituted by Asn. For those substituted, the net charge of the dual calcium site is
neutral rather than -1.
A cis-peptide bond forms between residues 901-902 of holo-s3b and 870-871 of holo-s3
(Fig 2). The residue equivalent to Asn902 in other CBD molecules is either Pro, Asp or Asn. Pro
frequently succeeds the peptide bond to ease trans-cis isomerization. In s3b, Asn902_OD1 and
Asp904_N form a critical hydrogen-bond for the peptide isomerization (37). For CBD molecules
where Asp succeeds the cis bond, side chain oxygen could play the same role as Asn902_OD1.
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Other hydrogen-bonds identified by simulation studies important in stabilizing the transition
states (37) are well conserved. The simulation study did not account for hydrogen-bonding via
water mediated interactions involving Lys900_O, Asn902_O, Lys908_O, and Thr910_OG1 that
are also conserved (Supplementary Table 6). Calcium ions could catalyze the isomerization in
all the CBD molecules and their transition states and catalytic mechanism may look very similar.
Conserved residues are important in ensuring either proper folding or architectural
stability. Hydrophobic residues packed between the β-sheets are better conserved if they are
located in the vicinity of functionally critical residues. For example, invariant Trp956 of strand E
is packed between the β-sheets. The residues flanking (Thr955 & Thr957) interact with minicollagen. Tyr932 is packed between the sheets and helps positioning Tyr1002. Residues at tight
turns are conserved as well. Gly975 is well conserved to allow a type II’ turn in s3b (29). Gly942
(Gly975 equivalent) in s3 allows Asp941 side chain to stabilize the reverse turn. A highly
conserved six-residue stretch, 986-991 (PGKYYL), adopts a tight turn and precedes the
functionally important strand H. The region is well ordered in the crystal structures with low Bfactors, and is the least dynamic based on NMR (45) and limited proteolysis MALDI-TOF MS
(64). The main-chain carbonyl and amino groups of Arg985 hydrogen-bond with OH of Tyr989
to stabilize the turn. Only Gly987 can make room for the bulky Tyr989 side chain. Tyr990 packs
against the invariant Ala909 and conserved 310 helix. Ala909 is at the base of the linker that
undergoes α-helixβ-strand transformation. The tight turn may ensure that collagen interacting
Leu992, Tyr994, and Tyr996 would be correctly positioned. Tyr994 is the most critical residue
in interacting with collagenous peptides (29). The strands adjacent to strand H, i.e. strands C and
E, are very well conserved. The three antiparallel strands mold the collagen-binding pocket.
Strand F staples the β-sheets by interacting with both sheets. The β-strand first interacts in an
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antiparallel orientation with strand E then breaks its direction at Gly971 to interact with strand G.
In place of Gly971, Ala or Pro is found at the location where the strand switches its allegiance.
The dual interaction of the strand helps positioning Tyr970 to interact with mini-collagen.
Three residues (Tyr970, Tyr994, and Tyr996) shown to interact strongly with minicollagen (29, 45) are conserved. Tyr996 of s3b is a critical residue in binding mini-collagen, and
is partially conserved. This residue is replaced with Phe in s3, though both side chains have
identical orientation. In other CBD molecules, an aromatic residue, such as Phe or His, is
sometimes found at the site. Meanwhile, either a -branched residue or Leu is found at the
position equivalent to Thr957 in most of the CBDs. Six other residues identified by 15N-HSQCNMR titration to interact with mini-collagen are not well conserved. Since divergent CBDs (s3
and s3b) adopted a similar cleft-shaped binding pocket, other CBDs may also adopt a similar
collagen-binding structure.
Divergent CBD could target different collagen sequences and could possibly target
different collagen types; however, this structural study suggests otherwise. Rather, all the CBD
domains may bind similarly to an under-twisted region such as the C-terminus of a collagen
fibril. The C-terminus of type I collagen is exposed in the fibril surface based on X-ray fiber
diffraction experiments (5), and it is the most accessible site for the bacterial collagenase to
initiate assaults. However, CBD binding only at the C-terminal region of tropocollagen is
unfounded. Gold particle-labeled tandem ColG-CBD (s3a-s3b) labeled with gold particle bound
to type I collagen fibrils exhibited no periodicity (44). In the collagen fibrils, the molecules are
staggered from each other by about 67nm. Therefore CBD could target partially under-twisted
regions in the middle of a tropocollagen that are also vulnerable for assaults (66). Both type I and
II tropocollagen molecules are suggested to consist of triple helix with some relaxations (75).
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Energetic requirement to unwind these regions could be much less than tightly wound helical
regions. Both s3 and s3b bind similarly to a mini-collagen, thus M9B collagenase molecules
could initiate collagenolysis from analogous structural features in various collagen fibrils.
Some bacterial collagenases consist of up to three CBD molecules. The linker that
induced structural transformation is a common feature found in M9B collagenase. It could act as
Ca2+ sensor to trigger domain rearrangement as means of enzyme activation against the insoluble
fibril. Physiological Ca2+ will likely trigger a domain rearrangement in these collagenases.
Properly positioned tandem and triple CBDs should ensure collagenase to be anchored to the
weakest region in fibril.
The function of the PPC domain in M9A (PPC-M9A) is unknown. Characterized M9A
are collagenases and the PPC domain from V. vulnificus is thought to interact with type IV
collagen (76). No structure of PPC-M9A has been reported. The crystal structure of PPC from
serine protease S8 superfamily with a sequence identity of 15% (PDB accession code 1WME
(77)) cannot offer additional insights either. The function of the PPC is not known, either, but
PPC-M9A may adopt a similar tertiary fold to that of CBD. Like s3, strand A in PPC-M9A may
not exist. The capability to monitor the concentration change in Ca2+ by CBD is critical for the
activation of M9B enzymes against insoluble collagen. Along with Zn2+ at the catalytic center, V.
parahaemolyticus M9A enzyme uses Ca2+ as a cofactor (78). However, neither Ca2+ binding
residues, nor collagen binding residues identified in CBD are found in PPC-M9A. The structures
of s3 and s3b could only serve as a template to the general fold of PPC-M9A.
As mentioned, clinical applications using fusion proteins of CBD and various growth
factors are underway. Fusion proteins of any CBD derived from M9B collagense and a growth
factor should result in comparable clinical outcome.
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Accession Codes
The full atomic coordinates of the CBDs and their corresponding structure factor
amplitudes have been deposited in the Protein Data Bank (PDB accession codes 4HPK, 3JQW,
and 3JQX assigned to Ca2+-bound s3b, Ca2+-bound s3, and Ca2+/Cd2+-bound s3).
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Tables
Table 1. Data collection and refinement statistics
Holo–s3b

Holo-s3

Wavelength (Å)

0.98045

0.97937

Space group

P21

P212121

a, b, c (Å)

40.9, 59.2, 48.8

62.0, 64.2, 95.4

beta()

100.4

90.0

Unique Reflections

44,856

26,207

Resolution (Å) (b)

16.61-1.35

28.50-2.00

Completeness (%) (c)

99.8 (100)

99.4(99.9)

I/σI (b)

26.3 (2.6)

16.7 (3.1)

Rmeas (%) (d)

6.4 (65.9)

9.9 (56.6)

Redundancies

4.6 (3.2)

4.0 (4.1)

Data collection statistics (a)

30

Table 1 (Cont.): Data collection and refinement statistics
Holo–s3b

Holo-s3

Resolution (Ǻ)

16.61-1.35

28.50-2.00

R-factor (%)

17.9 (30.9)

17.4 (19.5)

Rfree (%) 10% of data

21.0 (38.0)

23.3 (28.4)

Average B-factor main chain in A (A2)
Average B-factor side chain in A (A2)

11.6
14.2

25.2
27.5

Average B-factor main chain B (A2)

15.8

21.4

Average B-factor side chain B (A2)

17.8

23.8

Average B-factor main chain C (A2)

NA

23.4

Average B-factor side chain C (A2)

NA

26.2

Bond Lengths (Å)

0.01

0.02

Angle (°)

1.2

1.7

Distances form Restraint Planes

0.004

0.007

Refinement Statistics

RMS Deviations from restraint target
values

Ramachandran Statistics
Most favorable (%)
92.1
90.2
Additionally allowed (%)
7.9
9.8
Disallowed (%)
0.0
0.0
(a) For more complete data collection statistics, see Supplementary Tables 7 and 8.
(b) Highest resolution shell for holo-s3b: 1.40-1.35 Å. Highest resolution shell for holo-s3:
2.03-2.00 Å
(c) Data for the highest resolution shell are given in parenthesis
nh

(d) R meas = ∑h √n

h−1

∑l|Ihl − 〈Ih 〉|/ ∑h ∑l〈Ih 〉
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Table 2: SAXS derived molecular parameters
Mini-collagen:CBD
Complexes
[(POG)10]3:s3
[(POG)10]3:s3b

Small Angle X-ray Scattering (SAXS)
Dmax (Å)
87
93

Rg (Å) (expt)
23.11 ± 0.09
22.62 ± 0.04
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Rg (Å) (calc)
24.43
24.79

Discrepancy
χ2
0.47
0.75

Figures

N872

N873

E870

N903

E868

Ca1
Ca2

HOH

K929
T891

Ca2

HOH

S922
D927

D897
S896

E899

D904

Ca1

Q898

E091

A

B

Fig. 1: Ca2+ coordination in s3 and s3b. Comparison of Ca2+ coordination of s3 (A) and s3b (B):
For both CBDs, the pentagonal base around Ca1 is indicated by gray dashes, while the axial
positions are indicated by yellow dashes. Seven oxygen atoms from six residues interact with
this Ca2+. For Ca2 of both CBDs, one square face is indicated by blue dashes, while the other
face is indicated by green dashes. Seven oxygen atoms from five residues and a water molecule
interact with this Ca2+. Each oxygen atom is labeled with residue type and residue number. D897
of s3 fulfills the role of D927 of s3b.
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P864

D90
7

K869
P871
I865 G866
S874

K875

N872

N873

K900
K908

S906
S905
D90
4

Ca1

L897 K898

N903 E90
1
E89
9

E870
E868 T867

N902

Ca1

Ca2

E895

K896

Ca2

A

B

Fig. 2: Linker of CBD. (A) Close-up view of linker in s3 (ColH). The peptide bond between
Glu870 and Pro871 adopts prolyl cis conformation. Glu868, Glu870, Asn872 and Asn873 in the
linker region chelate with Ca2+ ions (brown spheres). (B) Close-up view of the linker in s3b
(ColG). The peptide bond between Glu901 and Asn902 adopts an energetically unfavorable
non-prolyl cis conformation. Glu899, Glu901, Asn903 and Asp904 in the linker region chelate
with Ca2+ atoms (brown spheres).
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Y970

Y937

F964

Y996

Y962

Y994
Y931

Y900
Ca1
Ca2

Ca2

Ca1

B

A

Fig. 3: Collagen-binding cleft of CBD. (A) Collagen-binding cleft in s3 (ColH). Conserved
residues Thr924, Val926, Tyr937, Tyr962 and Phe964 may shape the binding cleft. Tyr900
adopts a favorable 1 and it is facing the binding cleft. (B) Collagen-binding cleft in s3b.
Residues Ser928, Arg929, Thr957, Tyr970, Tyr994 and Tyr996 are the key residues shaping the
binding cleft. The collagen-binding cleft matches the width of collagen (~10Å). Tyr931 adopts
an atypical 1 angle.
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Ca1

Ca1

Ca2

Ca2

Fig. 4: Structures derived from SAXS scattering profiles using ab initio simulated annealing
calculations are shown as gray surface for s3-[G(POG)8]3 complex (A) and s3b-[G(POG)7PRG]3
complex (B) Calcium ions are shown in red.
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Holo-S3
Molar Heat Capacity (kcal/(mol*K))

40

35

30

Apo-S3
25

20
40

50

60

70

80

Temperature (deg C)

Fig. 5: DSC profile for both apo and holo s3
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90

100

110

Fig. 6: Results of fluorescence measured equilibrium denaturation of s3 in its apo form (closed
circles, and in its holo form (open circles). (A): Heat denaturation pathway of s3. (B): Urea
denaturation pathway of s3. (C): GuHCl denaturation pathway of s3.
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Fig. 7: Structure based sequence alignment of collagen-binding domains from M9B family.
Calcium chelating residues, those critical for cis-trans linker isomerization, collagen-binding
residues, and architecturally important residues are highlighted in red, yellow, blue and green,
respectively. Sequences alignment was aided by the use of ClustalW2 (79).
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Supplemental Material
Crystallization and Structure Determination of s3-Form II from ColH
The second form of s3 crystals were obtained by hanging drop vapor diffusion from 1.11.4 M sodium acetate, 0.1 M HEPES (pH 7.5), 1 mM CaCl2 and 0.05 M CdSO4. The crystals
were flash frozen in liquid nitrogen without the need of additional cryoprotectant. This crystal
form of s3 diffracted to 2.2Å resolution and was isomorphous to the first form. We were
planning to solve s3 structure by single isomorphous replacement method. Ca2+ ions and solvent
molecules were deleted from the ColH model described above before refinement using
REFMAC (52). The size of Fo-Fc difference peaks indicated that 12 of them are of cations. Two
cations per molecule were geometrically identical to Ca2+ bound to s3b and those of s3 in the
form I. Six peaks were therefore assigned as Ca2+. Later it became clear that the B-factor of one
of the two Ca2+ was too low (<5 Å2). It was therefore reassigned as Cd2+. The rest of the strong
Fo-Fc difference peaks were assigned as Cd2+ ions. Two Cd2+ ions are chelated with surface
glutamic acids (Glu876 and Glu930), respectively in each of the three molecules. The mainchain (Cα) root mean square deviation between Form I and Form II was only 0.35Å.
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Tables
Supplementary Table 1. Data collection and refinement statistics
Holo-s3 Form II
Data collection statistics
Wavelength (Å)

0.97937

Space group

P212121

a (Å), b (Å), c (Å)

61.6,64.6, 96.0

beta()

90.0

Unique Reflections

19,933

Resolution (Å) (a)

28.7-2.2

Completeness (%) (b)

98.8(99.7)

I/σI (b)

9.6 (2.4)

Rmeas (%) (c)

15.2 (54.0)

Redundancies

13.9 (3.4)
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Supplementary Table 1 (Cont.). Data collection and refinement statistics
Holo-s3 Form II
Refinement Statistics
Resolution (Ǻ)

20-2.2

R-factor (%)

17.6 (20.4)

Rfree (%) 10% of data

25.0 (27.2)

Average B-factor main chain in A (A2) 19.6
Average B-factor side chain in A (A2) 21.7
Average B-factor main chain B (A2)

18.3

Average B-factor side chain B (A2)

20.5

Average B-factor main chain C (A2)

19.4

Average B-factor side chain C (A2)

22.0

RMS Deviations from restraint target
values
Bond Lengths (Å)

0.02

Angle (°)

1.9

Distances form Restraint Planes

0.008

Ramachandran Statistics
Most favorable (%)
91.0
Additionally allowed (%)
9.0
Disallowed (%)
0.0
(a) Highest resolution shell for holo-s3 form II: 2.24-2.20
(b) Data for the highest resolution shell are given in parenthesis
nh

(c) Rmeas = R meas = ∑h √n

h−1

∑l|Ihl − 〈Ih 〉|/ ∑h ∑l〈Ih 〉
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Supplementary Table 2. Calcium-oxygen atom distances and deviation from planarity in
pentagonal bipyramid coordination.
Residue

E901

E901

D904

R929

D930

N903,
axial

D927,
axial

Atom

OE1

OE2

OD2

O

OD1

OD1

OD1

Ca2+

O-Ca2+
distances
(Å) (a)

Average
of
Molecules
A and B

2.56 (2)

2.41 (1)

2.34 (2)

2.36 (1)

2.35 (2)

2.35 (1)

2.43 (2)

3.75(1)

Distance
out
of
equatorial
LSQ plane
(Å) (ab)

Average
of
Molecules
A and B

0.29

0.32

0.21

0.19

0.15

NA

NA

0.05

s3-Form I

Residue

E870

E870

N873

Q898

D899

N872

D897

Atom

OE1

OE2

OD1

O

OD1

OD1

OD1

Ca2+

Average
of
Molecules
A, B and
C

2.56 (6)

2.45 (3)

2.34 (5)

2.39 (1)

2.38 (4)

2.34 (5)

2.28 (2)

3.77 (2)

Average
of
Molecules
A, B and
C

0.34 (5)

0.28 (9)

0.27
(12)

0.24 (8)

0.12 (6)

NA

NA

0.06 (4)

Residue

E870

E870

N873

Q898

D899

N872

D897

Atom
Average
of
Molecules
A, B and
C

OE1

OE2

OD1

O

OD1

OD1

OD1

Ca2+

2.62 (4)

2.55(10)

2.37 (5)

2.35 (6)

2.40 (4)

2.34 (5)

2.30 (1)

3.66 (3)

s3b

O-Ca2+
distances
(Å)
Distance
out
of
equatorial
LSQ plane
(Å) (ab)
s3-Form
II

O-Ca2+
distances
(Å)

A number within parenthesis represents an estimated standard deviation obtained after least
square refinement (2.54 (2) means 2.540.02 Å). Measurements are for the distance of specific
atom out of the plane created by the five members and do not include the axial members.
Additionally, the distance of calcium from each plane was also calculated.
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Supplementary Table 3: Calcium- oxygen atom distances and deviation from planarity in square
antiprismatic coordination.
s3b

O-Ca2+
distances
(Å) (a)
Distance
out
of
square
LSQ
plane
(Å) (ab)
s3-Form
I

O-Ca2+
distances
(Å)
Distance
out
of
square
LSQ
plane
(Å) (ab)
s3-Form
II

O-Ca2+
distances
(Å)

Residue

E899

E899

E901

H2O
2+

S922

D927

D930

D930

O

OD2

OD1

OD2

Atom

OE1

OE2

OE2

O

Ca

Average
of
Molecules
A and B

2.51
(2)

2.46
(1)

2.36
(2)

2.44

3.75
(1)

2.32
(2)

2.41
(2)

2.47
(1)

2.60
(2)

Average
of
Molecules
A and B

0.10

0.16

0.08

0.05

NA

0.02

0.02

0.03

0.03

Residue

E868

E868

E870

H2O

T891

D897

D899

D899

O

OD2

OD1

OD2

2+

Atom

OE1

OE2

OE2

O

Ca

Average
of
Molecules
A, B and
C

2.64
(10)

2.46
(7)

2.26
(4)

2.41
(5)

3.77
(2)

2.29
(6)

2.50
(1)

2.54
(5)

2.52
(3)

Average
of
Molecules
A, B and
C

0.05
(3)

0.05
(4)

0.03
(2)

0.04
(3)

NA

0.21
(11)

0.17
(7)

0.25
(10)

0.23
(11)

Residue

E868

E868

E870

H2O

T891

D897

D899

D899

Atom

OE1

OE2

OE2

O

O

OD1

OD2

Average
of
Molecules
A, B and
C

2.57
(13)

2.49
(6)

2.36
(8)

2.78

2.41
(7)

2.41
(1)

3.66
(15)

2.25
(11)

2.34
(3)

The two planar faces are listed separately. Measurements are for the distance of specific atom
out of the plane created the four members of each face. Again, a number within parenthesis
represents the standard deviation obtained after least square refinement.
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Supplementary Table 4. Deviation from planarity in square antiprisms found in proteins.
Protein

s3b

s3

2AAA

3TEC

2PRK

1JPQ

1K4C

Resolution (Å)

1.4

2.0

2.1

2.0

1.5

1.6

2.0

Ion

Ca2+

Ca2+

Ca2+

Ca2+

Ca2+

K+

K+

Average planar
deviation (Å)

0.08

0.01

0.14

0.12

0.01

0.02

0.0

Average ionto-ligand
distance (Å)

2.58

2.45

2.59

2.45

2.48

2.78

2.83

PDB access codes are for proteinase K (2PRK), alpha amylase (2AAA), thermitase (3TEC), Gquadruplex (1JPQ), and KcsA potassium channel (1K4C). The planes for 1K4C are defined by
crystallographic symmetry.
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Supplementary Table 5: Stability information of apo and holo s3
Apo-s3
Parameters
Heat
Urea GuHCl
Heat
ΔGHOH (kcal*mol-1)
m (kcal*mol-1*M-1)
CM (M)

5.2
0.1
NA

1.7
0.6
2.7

1.8
2.3
0.8

TM (°C)
70.2a 64.6b
NA
NA
(a) Value represents TM for DSC data shown in Fig-5.

GuHCl

NA
NA
NA

9.6
1.5
6.5

8.1
4.2
1.9

94.1a >100b

NA

NA

(b) Value represents TM for denaturation curve shown in Fig-6A
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Holo-s3
Urea

Supplementary Table 6: Conserved water mediated hydrogen-bonds in s3 and s3b.
HOH mediated H-bonds in s3b HOH mediated H bonds in s3
K908_O...HOH...T910_OG1
T877_O...HOH...S87_OG1
K900_O...HOH...T910_OG1
K869_O...HOH...S87_OG1
K908_O...HOH...N902_O
T877_O...HOH...P87_O
A909_O…HOH…K900_O
A878_O…HOH...K86_O
K908_O…HOH…T910_OG1 indicates that a water molecule is found between carbonyl oxygen
of K908 and side-chain alcohol group of T910.
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Figures

Supplementary Figure 1. SAXS data of s3-[G(POG)8]3 complex (blue) and s3b-[G(POG)7PRG]3
complex (red). (A) The scattering profile where the intensity, I(Q) is plotted against scattering
vector Q. (B) Pair-distance distribution function P(r) in the real space.
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Supplementary Figure 2. Superimposed structure of s3 (salmon) and s3b (green), showing that
Y900 of s3 occupies the three-dimensional space of R929 of s3b and that T895 of s3 occupies
the three-dimensional space of S928 of s3b.
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Supplementary Figure 3. SAXS curves of s3-[G(POG)8]3 complex (A) and s3b-[G(POG)7PRG]3
complex (B) are compared to the theoretical scattering durve. The theoretical Rg values
calculated from the models by using CRYSOL (61)are in excellent agreement with the
experiemental curves (Table-2). Rigid body model with lowest  value for s3-[G(POG)8]3
complex (A) and s3b-[G(POG)7PRG]3 complex (B) are also shown.
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Chapter 3: Structures of three polycystic kidney disease-like domains from Clostridium
histolyticum collagenase ColG and ColH
Abstract
Clostridium histolyticum collagenases ColG and ColH are segmental enzymes that are thought to
be activated by Ca2+-triggered domain reorientation to cause extensive tissue destruction. The
collagenases consist of a collagenase module (s1), a variable number of polycystic kidney
disease-like (PKD-like) domains (s2a and s2b in ColH; s2 in ColG), and a variable number of
collagen-binding domains (s3 in ColH; s3a and s3b in ColG). The X-ray crystal structures of
Ca2+ bound holo-s2b (1.4 Å resolution, R = 15.0%, R-free = 19.1%) and holo-s2a (1.9 Å
resolution, R = 16.3%, R-free = 20.7%), as well as Ca2+ absent apo-s2a (1.8 Å resolution, R =
20.7%, R-free = 27.2%) and two new forms of N-terminal truncated apo-s2 (1.4 Å resolution,
R=16.9, R-free=21.2%; 1.6 Å resolution, R=16.2, R-free=19.2%) are reported. The structurally
similar PKD-like domains resemble the V-set Ig fold. In addition to a conserved β-bulge, the
PKD-like domains feature a second bulge that also changes the allegiance of the subsequent βstrand. This β-bulge and the genesis of a Ca2+ pocket in the archaea PKD-like domain suggest a
close kinship between bacterial and archaeal PKD-like domains. Different surface properties and
indications of different dynamics suggest unique roles for the PKD-like domains in ColG and in
ColH. Surface aromatic residues found on ColH-s2a-s2b, but not on ColG-s2, may provide the
weak interaction in the biphasic collagen-binding mode previously found in s2b-s3. B-factor
analyses suggest that in the presence of Ca2+, the midsection of s2 becomes more flexible, but the
midsections of s2a and s2b stay rigid. The different surface properties and dynamics of the
domains suggest that PKD-like domains of M9B bacterial collagenase can be grouped into either
a ColG-subset or ColH-subset. Conserved properties of PKD-like domains in ColG and in ColH
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concern Ca2+ binding. Conserved residues not only interact with Ca2+, but also position the Ca2+
interacting water molecule. Ca2+ aligns the N-terminal linker approximately parallel to the
domain’s major axis. Ca2+ binding also increases stability against heat and guanidine
hydrochloride, and may improve their longevity in ECM. The results of this study will further
assist in developing collagen-targeting vehicles for various signal molecules.
Introduction
Clostridium histolyticum collagenases are causative agents for gas gangrene. The two
classes of collagenase, ColG and ColH, differ in domain structures (s1, s2, s3a, s3b for ColG; s1,
s2a, s2b, s3 for ColH) (43) (Fig. 1), and work synergistically to degrade collagen fibers (32). S1
is the collagenase module that belongs to the metallopeptidase subfamily M9B. The amino acid
sequences of s2, s2a and s2b resemble the polycystic kidney disease domain (PKD) that was first
identified in the polycystic kidney disease protein PKD1 (The International PKD Consortium,
1995). The C-terminal domains s3a, s3b and s3 are collagen-binding homologues that are a
subclass of bacterial pre-peptidase C-terminal domains (PPC super-family) (29, 45, 66, 80). The
collagen-binding segment composed of the PKD-like domain and CBD is not necessary to
degrade gelatin (denatured, non-triple helical collagen) and acid solubilized collagen. The
segment, however, is necessary to degrade insoluble collagen fibers.
Understanding the interaction of Ca2+ is significant due to its role in regulating both
stability and enzyme activity in the ECM (30, 80, 81). Full-length ColH has been shown to
undergo Ca2+ dependent structural changes demonstrated using SAXS and limited proteolysis
(81). In ColG, Ca2+ triggers the linker between s3a and s3b to undergo secondary structure
transformation from an α-helix to a β-strand to increase collagen affinity (29, 64). Similar to the
N-terminal linker structure of s3b (30), the N-terminal linker structure of the PKD-like domain is
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also thought to be Ca2+ dependent, and thus, high-resolution structures of both apo and holo
states for the PKD-like domains are needed in order to elucidate their activation mechanism.
Thus far crystallographic methods have been used to describe apo-s1 from ColG (31), the holopeptidase sub-domains of ColH (82), apo- and holo-s2 (31, 82), apo- and holo-s3b of ColG (29),
and holo-s3 of ColH (80). In the apo-s2 structure, however, the conserved Pro688 near the Ca2+
binding site was mutated to Thr. As a side note, we use amino acid sequence numbering for the
mature enzymes. Numbering for s2b and s2a accounts for cleavage of a 40 amino acid prepropeptide present in ColH, while numbering for s2 accounts for cleavage of a 110 amino acid
prepro-peptide present in ColG. In this paper, we describe crystal structures of ColG, and for the
first time, ColH PKD-like domains. Thermal and chemical stability differences upon Ca2+binding for the PKD-like domains are also reported.
The collagenolytic mechanism between mammalian matrix metalloproteinases (MMP)
and bacterial collagenase differ (18, 83). Unlike bacterial collagenases, MMPs are sequence
specific and proposed to actively unwind the triple-helix (84-87). Meanwhile, each domain in
bacterial collagenase is believed to play a unique role in collagenolysis (88). The C-terminal
CBD unidirectionally binds to under-twisted sites in the triple-helical collagenous peptide (66,
80). The CBD does not unwind mini-collagen, and hence, targeting under-twisted regions of
tropocollagen may circumvent the energy barrier required for unwinding the helix. Various roles
for the PKD-like domains have been proposed. The PKD-like domain has been shown to swell,
but not unwind collagen fibrils (39). Clostridial PKD-like domains do not bind tightly to
collagen fibril (40, 43), though s2b has been shown to enhance s3’s ability to bind to the collagen
fiber. S2b-s3 binding is biphasic; the initial low affinity (Kd = 2.11 x 10-6 M) leads into higher
affinity (Kd = 3.39 x 10-7 M) (40). The N-terminal collagenase module, s1, has a two-domain
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architecture that disbands the collagen microfibril into monomeric triple-helices, and then
cleaves the exposed peptide bond preceding the Gly residue (31, 82). Crystallographic packing
analysis of s2 suggested a side-by-side assembly of s1, s2, s3a and s3b that matched the width of
the collagen microfibril (31, 89). The proposed holo-ColG structure is compact; s2 helps align
the active site of s1 with the binding clefts of s3a and s3b. In contrast, the solution envelope of
ColH resembled a tadpole (81), and thus, the role of its PKD-like domains of ColH could differ
from that of ColG. The work presented here provides structural framework to better decipher the
role of the PKD-like domain.
Despite their detrimental role in bacterial infection, bacterial collagenases and their
collagen-binding segments are investigated for therapeutic applications. A cocktail of C.
histolyticum ColG and ColH is used in both the nonsurgical treatment of Dupuytren's contracture
(38), and the isolation of pancreatic islets (90, 91). Other applications are in preclinical stages
(18). Moreover, fusion proteins consisting of growth factors, cytokines, or hormones and the
collagen-binding segment s2b-s3 are non-diffusing and long lasting at wound sites (46, 92-94),
and hence, the binding segments are being developed as drug-delivery vehicles. Therapeutic
strategies based on these results are proposed to enhance efficacy by minimizing the quantity of
signal molecules necessary and reducing side effects. In contrast, bone distribution of the fusion
protein of parathyroid hormone with s3 only (PTH-s3) was efficacious in bone mineral density
increase in osteoporotic models, though fusion proteins of PTH-s2b-s3 demonstrated little
efficacy (48-50, 95). When applied to skin, PTH-s3 was efficacious in hair follicle regeneration
in alopecia models (47, 96). This study of PKD-like domains is necessary for commercialization
and optimization efforts for various drug candidates.
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Methods
Expression and purification of s2a, s2b and s2
Expression and purification of each PKD-like domain as a glutathione S-transferase
(GST) fusion protein was achieved using previously described methods (43).
15

N-HSQC NMR characterization of apo-s2
Though stably folded and monodispersed in solution, s2 with its N-terminal linker did not

crystallize.
15

15

N enriched apo-s2 was made to measure the dynamics of the protein using NMR.

N enriched s2 was prepared as described (97). NMR experiments were performed at 298 ± 0.5

K on a Bruker 700 MHz spectrometer equipped with cryoprobeTM. The concentration of the
protein used was 0.1 mM in 50 mM Tris-HCl (pH 7.5). In the HSQC spectra, thirteen residues
could not be identified due to band broadening (Supplemental Fig. 1). Using the homology
modeled s2 (based on PDB ID 2C4X (98)), we reasoned that unobserved HSQC peaks
corresponded to a highly dynamic N-terminus that hindered crystallization. Guided by the
solution data, thirteen residues were truncated from the N-terminus. The truncated s2
crystallized readily.
Crystal structure determination of PKD-like domains
Initial conditions suitable to grow apo-s2a, holo-s2b, and the two forms of apo-s2
crystals were identified by the sitting drop method using a high throughput screen (Hampton
Research Crystal Screen HT). Subsequent crystallization trials using the initial conditions were
carried out using the hanging drop method. Apo-s2a (at a concentration of 30.5 mg/mL) was
crystallized from 3 M (NH4)2SO4, 0.1 M MES (pH 4.5), and 15% (w/v) PEG 4000 at 290 K,
whereas holo-s2a (4.8 mg/mL) was crystallized from 30% (w/v) PEG 4000, 0.2 M MgCl2, and
0.1 M Tris-HCl (pH 8.5) at 17C. These crystals were subsequently soaked in 15% (w/v) PEG
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4000, 0.2 M MgCl2, 50 mM CaCl2 and 0.1 M Tris-HCl (pH 8.5) before initial unit cell
characterization and data collection. Meanwhile, holo-s2b (13.7 mg/mL) was crystallized from
35% (w/v) PEG 5000, 0.2 M ammonium sulfate, and 0.1 M MES (pH 6.5) at 277 K. Both crystal
forms of s2 (12.0 mg/mL) were grown from 41-49% 2-methyl-2, 4-pentanediol (MPD), 100 mM
Bis-Tris (pH 5.5) and 0.1-0.3M ammonium acetate at 277 K. The in-house X-ray diffraction
facility (Rigaku 007, Osmic Blue confocal mirrors, Saturn CCD detector) was used for initial
characterization of each PKD-like domain crystal, and in the case of the s2a crystals, was also
used for data collection.at 113 K. s2b and s2 crystals were cryo-cooled and subsequently stored
in liquid nitrogen until data collection. Diffraction data were collected at 109 K, in the 19-ID
beamline of the Advanced Photon Source at Argonne National Laboratory.
Each s2a data set was indexed and scaled using d*trek (99) whereas each s2b and s2 data
set was indexed and scaled using HKL-3000 (53). In each case, a data set truncated to 3 Å was
used for molecular replacement using PHASER (51). The PKD-like domain from the
carbohydrate-binding module (PDB code 2C4X) was used as the search model during structure
determination of s2. s2 Form I was subsequently used as the search model during structure
determination of s2a and s2b. Four molecules were found in the asymmetric unit (ASU) of apos2a crystals, while eight molecules were found in the ASU of holo-s2a crystals. Meanwhile, two
molecules were found in the ASU of holo-s2b and each form of apo-s2 crystals.
The subsequent structure determination for each model was accomplished using an
iterative process of manual adjustments aided by the use of MIFit (55) and refinement using
REFMAC(52). During manual adjustments, ARP/wARP (100) was used to place water
molecules. Rfree was lowered for s2 Form I, apo-s2a, and holo-s2a models by utilizing Babinet’s
principle for bulk solvent scaling. In each s2a model, Rfree was also lowered by applying TLS
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and tight NCS restraints. The s2a models were refined with isotropic B-factors, whereas s2-Form
I and s2b models were refined with anisotropic B-factors. PARVATI (101) calculated the
anisotropy of s2b and s2 to be 0.5 ± 0.1 and 0.4 ± 0.1 respectively. Isotropic B-factors would
result in anisotropy of 1.0. Each model exhibited excellent geometry as analyzed by MolProbity
(102). Full data collection and refinement statistics are summarized in Table 1 for s2a, s2b, and
s2 Form I and in Supplemental Table 1 for s2-Form II. Alternate conformations are detailed in
Supplemental Table 2.
Fluorescence spectroscopy measured equilibrium denaturation of PKD-like domains
PKD-like domains share similar topology, and unfolding of each domain was monitored
by the change in intrinsic fluorescence of a conserved Trp residue. All experiments were carried
out at room temperature on a Hitachi F-2500 fluorimeter with excitation and emission
bandwidths at 2.5 nm and 10 nm, respectively. The excitation wavelength used was 280 nm, and
fluorescence emissions were monitored between 300 nm and 450 nm. For s2b, s2a, and s2, λmax
for the folded state occurred at 325, 328, and 327 nm, respectively. For each domain, λmax for the
denatured states occurred at 350 nm. The ratio of intensity at 350 nm verses the intensity at the
native state λmax was used to track the unfolding process. During thermal denaturation trials, the
temperature of the protein solution was maintained with a Neslab RTE-110 circulating water
bath (Thermo Scientific, Newington, NH). In the thermal denaturation trials for s2b and s2, the
protein concentration was 3 μM. In the chemical denaturation trials, the protein concentration
was 1.5 μM. In case of s2a, protein concentration for both thermal and chemical denaturation
was 5M. Each holo-PKD-like domain was supplemented with 2 mM CaCl2, while each apoPKD-like domains was supplemented with 2 mM EDTA. In all cases, the protein was diluted in
10 mM Tris-HCl (pH 7.5) and 100 mM NaCl. When heat was used as the denaturant, each
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domain was exposed to temperatures that linearly elevated from 280.5 to 363 K in 2.5 K
increments. When guanidine hydrochloride (Gu.HCl) was used as the denaturant, each domain
was exposed to concentrations of denaturant that increased linearly from 0.0 to 5.8 M in 0.2 M
increments. ΔGHOH, CM, and m values were calculated as described previously (30, 80).
Results and Discussion
The X-ray crystal structures of Ca2+ bound holo-s2a (C2), Ca2+ absent apo-s2a (P61),
Ca2+ bound holo-s2b (P21), and two new forms of N-terminal truncated wild-type apo-s2 (P21,
P212121) are reported for the first time. Between the novel s2a and s2b structures, s2b was solved
at higher resolution, and correspondingly, is described in the most detail. New insights into s2
are subsequently reported.
Overall structure descriptions of apo and holo-s2a
In the following discussion, holo-s2a will be described first (Fig. 2A). The eight holo-s2a
molecules are virtually identical (average RMSD = 0.2 Å ± 0.1 Å). Here, the molecules spiral
along the crystallographic (1, 0, 1) axis. Along this axis, molecule pairs A and G, B and E, C and
F, and D and H are related by NCS translation that results in an off-origin peak that is 63.9% of
the origin peak in the Patterson map.
Similar to the molecules in the holo-s2a crystal, the four apo-s2a molecules are similar (average
RMSD = 0.5 Å ± 0.2 Å) with molecules C and D being the most similar (RMSD = 0.2 Å), and
molecules A and D, being the most divergent (RMSD = 0.8 Å). Molecules A and B, as well as
molecules C and D, are non-crystallographic two-fold related. Temperature factors for each
structure are relatively high (Table 1), possibly as a consequence of the high solvent content in
the crystal (61.8%).
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The holo and apo structures resemble each other (RMSD = 0.6 Å ± 0.2 Å). As expected,
the most notable difference between the structures occurs near the N-terminus, where Ca2+
reorients interacting residues Asn685 and Ser686. While neither structure could be refined using
anisotropic B-factors, comparison of B-factors revealed that with the exception of N-terminal
residues, no significant change in B-factor upon Ca2+ binding occurred.
Unlike s2b or s2, s2a truncates β-strand A through an approximately 126° rotation of the
ψ bond of Ile692. To accommodate the change, Tyr696 packs with Phe706 and is involved in a
Δ4 Tyr corner, in which the side chain hydroxyl group hydrogen bonds with the backbone four
residues prior to it (103). Interestingly, the Tyr corner also stabilizes the non-prolyl cis-peptide
bond between Gly694 and Thr695 of s2a that forms the bulge that realigns β-strand A’ to interact
with β-strand G (Fig. 2A and 2B). A second bulge between β-strands B and B’ is stabilized by a
hydrogen bonding network that features a monodentate interaction between Asn735 and Ser708.
Overall structure description of holo-s2b
Similar to holo-s2a, the two NCS related holo-s2b structures are virtually identical
(RMSD = 0.4 Å). In the structures, one Ca2+ was found near the N-terminal linker (Fig. 2C).
Each holo-s2b structure begins from residue 766 and the last residue is 860. The PKD-like
domain resembles a V-set Ig fold that lacks strand D (β-strand C’ of the Ig fold correspond to βstrand D of the PKD-like domain fold). β-Strands, B and F in the PKD-like domain structures are
shorter than the corresponding β-strands of a prototypical V-set Ig fold (PDB ID 1BRE (104)),
while strands F and G in the PKD-like domains are longer than the corresponding β-strands in
the V-set Ig fold. In the PKD-like domain structures, β-strands A, A’, B, B’, and E form one
sheet, while strands C, D, F, and G form the opposing sheet. β-strands A’ and G form a parallel
β-sheet, while the remaining strands form anti-parallel β-sheets. Meanwhile, β-strand B forms a
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sheet with β-strand E, with the exception of Tyr796 which is aligned with β-strand A. Given the
β-sheet sandwich fold, the PKD-like domain was predicted to resemble the CBD (41), though
structural alignment of holo-s2b with holo-s3 (PDB ID 3JQW (80)) suggests little homology.
Two prominent features are the conserved bulges in the domain that interrupt β-strands A
and B and help to form a ridge along the ABE face (Fig. 2). The first bulge occurs when Pro784
breaks β-strand A and pushes the subsequent Lys785 outward, which in turn leads to an
approximately 127 angle between β-strands A and A’ that also changes the allegiance of βstrand A’ to β-strand G. The second conserved bulge is introduced by Lys798 and Gly799. This
bulge removes the backbone hydrogen bonding partner of Tyr780 of β-strand A. To help
stabilize the bulge, the side chain hydroxyl group of conserved Thr800 hydrogen bonds with the
backbone amide of the Tyr780. To further stabilize the bulge and position the hydroxyl group of
Thr800, the carbonyl oxygen of Gly797 hydrogen bonds with the side chain hydroxyl group and
main chain amide of Thr800. The bulge is also stabilized by conserved Asn825 hydrogen
bonding with the amides of Gly797 and Lys798 (Fig. 2C). The second bulge helps form a
prominent ridge. Surface exposed aromatic residues are found at both sides of the ridge and are
discussed later.
Temperature factors for both NCS related structures are low (average B-factor for
molecule A = 11.7 Å2; that of molecule B = 9.9 Å2). Anisotropic B-factor analyses using the
Anisotropic Network Model web server (ANM) (105) showed that the main-chain is mostly
isotropic and potential correlated movement occurred exclusively at the N-terminal linker. The
calcium coordination for both holo-s2b and holo-s2a is described in detail in a later section.
Structure descriptions of apo-s2

60

Despite being solved in two crystal forms, the the crystal structures of Forms I and II of
apo-s2 from ColG are similar. Each ASU contains two non-crystallographic two-fold symmetry
related molecules. All four molecules are virtually identical to each other (RMSD < 0.5Å). Each
structure begins from residue 685, though the first two residues (Gly-Ser) are remnants from
GST-tag cleavage. The last residue is either 770 or 771. The NCS related molecules are
stabilized by anti-parallel type inter-molecular interaction between β-strand A. Comparison of
our apo-s2 structures to the previously solved apo-s2 (PDB code 2Y72), in which conserved
Pro688 is mutated showed that the N-terminal mutation pushes the N-terminus out by 3 Å at the
Cα of Ala687. Furthermore, while residues that make up the previously described bulges are
conserved, the interaction pattern does slightly differ from the pattern found in s2a and s2b.
Here, the hydroxyl group of Ser707 mediates the interaction between conserved Asn735 and the
backbone amides of Gly708 and Lys709 (Fig. 2D).
Structure based sequence comparisons of PKD-like domains
The sequence comparison of divergent PKD-like domains revealed conserved residues
that are essential for the overall fold and Ca2+ chelation. Residues involved in Ca2+ chelation will
be discussed in the subsequent section. Peptidase M9 family members are all thought to be
collagenase and consists of subfamily A (Vibrio) and B (Bacillus and Clostridium). M9A
enzymes lack CBD, and consequently may utilize different approaches to collagenolysis.
Therefore, this section will discuss M9B derived PKD-like domains exclusively, and will utilize
s2b numbering. PKD-like domain found in M9B enzymes share two conserved clusters of
residues (Fig. 3). The first conserved stretch,

DxDGxIxxYxWDFGDG817, contains β-strand C

802

(Underlined residues adopt the β-strand). The stretch is conserved for its Ca2+-binding and
architectural importance. The first two Asp residues chelate with Ca2+. Invariant Tyr810 is
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accommodated by the second β-bulge. Asp813 is sometimes replaced with an acidic Glu residue.
The side-chain of Glu may easily fulfill the role of the side chain of Asp813, which terminates βstrand C and stabilizes the subsequent sharp turn by hydrogen bonding to the amide of Gly815.
Phe814 stacks against conserved His828 so that the imidazole ring can also form a salt-bridge
with conserved Asp816. Gly817 allows Asp816 to also stabilize the turn by hydrogen bonding to
the amide of Ser818. Though a sharp turn follows β-strand C in all PKD-like domains, the type
of turn is different. In s2b, the insertion of Asp819 results in the region adopting an ω-loop
(ii+10). Both s2a and s2 lack Asp819 in this stretch, and subsequently, each is involved in an
α-turn
825

(ii+4)

that

forms

a

β-hairpin.

The

second

conserved

stretch,

NPxHxYxxxGxYxVxLxVxDxxG847, forms β-strands E and F. Tyr830 and Tyr836 stack

against each other to stabilize the interactions between the sheets. Tyr836 further stabilizes the
sheets by forming a Δ4 Tyr corner. Asp844 is responsible for one of the axial interactions with
Ca2+. The β-strands also wrap around the conserved turn and β-strand C to form the most unique
feature of the PKD-like domain. Gly847 allows for β-strands F and G to be separated by a β-turn
(ii+3).
Ca2+ chelation in s2a and s2b
Ca2+ coordination in s2a, s2b, and s2 are virtually identical to each other. Since holo-s2
has been described, this section describes the binding sites on s2a and s2b in detail. One calciumbinding site, consisting of pentagonal bipyramidal geometry, was identified near the N-terminus
in each domain (Fig. 4). The pentagonal base is composed of OD1 of Asn685, the main chain
carbonyl of Ser686, OD1 and OD2 of Asp713, and a water molecule, while the axial positions
are filled by OD1 of Asp715 and OD2 of Asp754. Ca-O bond distances and planar deviations
amongst oxygen atoms responsible for the pentagonal base (Table 2) are similar to values found
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in clostridial CBDs (80). The Ca2+ coordination geometry in PKD-like domains has been
described as octahedral (89, 98), though our results demonstrate that water is involved in forming
a pentagonal base. The coordinating water molecule is positioned by OD1 of Asp755 (Fig. 4A).
Calcium coordination in s2 (4AQO) (82) resembles that of s2a. Both the water and calcium ion
are ordered (B-factor < 8.1 Å2). Based on the sequence alignment (Fig. 3) of PKD-like domains,
residues contributing side chain interactions with calcium are strictly conserved. s2b chelates
with a Ca2+ ion very similarly, except for the residues that position the water molecule (Fig. 4B).
s2b utilizes OG from both Ser845 and Ser846 in lieu of Asp755 in s2a.
Ca2+ induced structural change
Ca2+ chelation appears to align the N-terminal linker approximately parallel to the
domain’s major axis (Supplemental Fig. 2). In s2b, Ca2+ chelation by Asn774 and Lys775 could
stabilize a 310 helix (residues 770-774) that aligns with the cylinder axis. In s2 and s2a, Nterminal residues are positioned so that the N-terminal linker could also be positioned parallel to
the domain’s major axis. The residues prior to Asn685 cannot be observed in the electron
density, and consequently, the region’s secondary structure remains ambiguous. Structural
comparison of the Ca2+-binding site between the apo- and holo-PKD-like domains revealed that
Ca2+ has varied influence on the loop between β-strands B’ and C. Proline, positioned between
aspartates equivalent to Asp802 and Asp804, restricts the loop flexibility so that minimal change
occurs between apo and holo states. However, in s2, which does not have a proline positioned
between Asp713 and Asp715, the Ca2+ interaction moves Asp715 2 Å from the binding site
(Supplemental Fig. 2C).
Overall, average B-factors of s2b and s2 are low, and average B-factors amongst apoand holo-s2a are similar (Table 1). Despite different symmetry interactions, the B-factor per-
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residue trend of 18 PKD-like domains (eight holo-s2a molecules, four apo-s2a molecules, two
holo-s2b molecules, and four apo-s2 molecules) are very similar to each other (Supplemental
Figure 3A-D). Holo-s2, however, does not follow this trend (Supplemental Figure 3E).
Comparison of holo and apo structures revealed a stark contrast between s2a and s2 in the
influence of Ca2+ (Fig. 5A and 5C). Drops in Cα B-factor in the holo-s2 are found in three
stretches (Gly698-I704, Gly708-Tyr721, and His738-Thr761) that are immediately preceded by
stretches where the B-factor is higher (Lys691-Thr697, Glu705-Ser707, and Gly733-Val737). In
the holo-s2 structure, the mid-section became more flexible, though both terminal regions
became more rigid. Differences in crystal packing could account for the dynamics reversal,
though it is possible that the crystal packing is a consequence of dynamic changes. Both termini
of holo-s2 are pinned down by symmetry related molecules that could suppress their dynamics,
while the mid-section of the barrel lacks the inter-molecular interactions observed in the apostate. In apo-s2, intermolecular anti-parallel β-sheet interactions involving β-strand A could
suppress dynamics of the region.
In contrast, comparison of holo-s2a and apo-s2a structures revealed that Ca2+ did not
increase the B-factor of mid-section (Fig. 5A). In the s2a structures, the termini are the most
flexible. As mentioned, B-factor trends in all holo- and apo-s2a structures are similar despite the
difference in crystal packing. Cα B-factors for the mid-section of holo-s2b are low (Fig. 5B), and
suggest that s2b behaves similarly to s2a. Overall, the starkly contrasting dynamics between
ColG and ColH derived PKD-like domains suggest diverging roles during collagenolysis.
Ca2+ induced stability gain of PKD-like domains
The apo-state of s2a, s2b, and s2 are thermally stable proteins (TM ~373 K), but they gain
further stability in the presence of Ca2+. In s2b, the fluorescence of Trp812 was monitored, while
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in s2a and s2, the fluorescence of Trp723 was monitored. During fluorescence monitored thermal
denaturation, none of the PKD-like domains fully unfolded in the holo state (Fig. 6A-C). Such
hyper-thermostability was also observed for holo states of s3 (80) and s3b (30). The stability of
both PKD-like domains and CBD may allow prolonged collagenolytic activity in the ECM. Heat
is thought to denature proteins by disrupting electrostatic interactions. As such, the conserved
hydrogen bonding network around the bulges may play a strong role in overall stability of the
domains, while the Ca2+-O interactions may contribute to increased stability in the holo-state.
PKD-like domains consist of a conserved (shown in green in Fig. 3), well-packed core, and are
likewise stable against Gu.HCl denaturation. Here, denaturation occurs through a cooperative
transition from the folded state to unfolded states (Fig. 6D-F). In contrast to heat, Gu.HCl is
thought to denature protein by predominately disrupting hydrophobic interactions (106). Of the
three domains, s2b is the most stable (Table 3). The difference in ΔGH2O between apo and holo
states (ΔΔGH2O) is approximately the same for all PKD-like domains. In addition to reorienting
the N-terminal linker, the proposed Ca2+-induced helical base of the N-terminal linker may have
a partial capping effect that shields the core against Gu.HCl. It is also well documented that
metalloproteins are more stable in the presence of their metal ligand (107).
In the clostridial collagen-binding domain, Ca2+-induced stability could be partially
accounted for by a reduction in void volume and an increase in hydrogen bonds (30). Analysis of
void volume of PKD-like domains using CASTp (108) revealed a common cavity located near
the N-terminus shrinks. The common cavity located near the C-terminus of the holo and apo
pairs of both s2a and s2 curiously remains essentially unchanged upon Ca2+ binding.
Furthermore, Ca2+ binding does not lead to a significant, change in hydrogen bond totals in any
of the domains (Supplemental Table 3). For therapeutic applications, in vitro stability of s2b and
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s3 may explain the prolonged activity of growth factors and signal molecules when fused to s2bs3 in vivo.
Surface Characteristics of ColG and ColH PKD-like domains
s2a and s2b, unlike s2, respectively contain two and four surface aromatic residues that
are located on the ABE face (Fig. 7A and 7B). Interestingly, these residues are also located along
the previously mentioned ridge. These residues could be involved in collagen binding given that
aromatic residues are found at the hot-spot of the collagen-binding pocket in CBD. In s3b,
mutations of Tyr970, Ty994, and Tyr996 to Ala greatly reduced binding to collagenous peptide
as monitored by surface plasmon resonance (29). NMR studies also showed that these aromatic
residues are involved in collagen binding (45). The structure-based sequence alignment of PKDlike domains (Fig. 3), suggest that the PKD-like domain of collagenases consisting of only one
CBD will likely contain surface aromatic residues. Conversely, the PKD-like domain of
collagenases consisting of multiple CBDs, such as s2, appears to have no surface aromatic
residues. Collagenases from B. brevis, C. botulinum, and C perfringens contain multiple CBDs.
Their respective PKD-like domains lack aromatic residues, and hence, may not directly interact
with collagen.
A putative structure of holo-ColH can be built from the homology modeled activator
domain of s1 and helical linker (residues 7-301 based on PDB ID 2Y50), and the crystal
structures of the peptidase domain (residues 302-681, PDB ID 4AR1), s2a (residues 685-770),
s2b (residues 766-860), and s3 (residues 861-981, PDB ID 3JQW). The overall dimensions
(length = 133 Å, height = 36 Å, width = 88 Å) match the tadpole shape observed in the SAXS
envelope of holo-ColH (81). In the model, the five-residue overlap between s2a and s2b
structures was superimposed (RMSD = 1.0 ± 0.1 Å) to assist with formation of the s2a-s2b
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segment. The aromatic residues mentioned are found on one side of s2a-s2b (Fig. 7C). In this
model, the surface aromatic residues on s2a-s2b may either span across multiple tropocollagen
molecules on the surface of the fibril or bind along one tropocollagen molecule when the binding
surface of s3 is docked onto the collagen fibril surface. The interactions may serve to prevent the
collagen-binding segment from diffusing away after the s3-collagen interaction is transiently
broken. Likewise, the domains may provide loose contacts with the collagen fibril that allow the
enzyme to scan the fibril surface for optimal regions for tight CBD interaction. In these roles, the
PKD-like domain strengthens collagen avidity so that only one CBD is required for collagen
binding. The zinc ion involved in activation of a water molecule is approximately 115 Å away
from Tyr962 found in the collagen-binding pocket of s3. In this model, the PKD-like domains
may also be critical in positioning the catalytic domain with respect to CBD.
Potential role of PKD-like domains in synergistic collagenolysis
The apparent differences between the ColG derived PKD-like domain and the ColH
derived PKD-like domains may aid synergistic collagenolysis. The putative holo-ColH structure
and the structure-based insights on the PKD-like domains allow us to begin to speculate on how
ColG and ColH work together to degrade collagen. Currently, it is not known whether any of the
clostridial PKD-like domains swell collagen fibers. Both s3 and s3b share a common preference
for under-twisted regions of collagen (80), though ColG and ColH initially cleave different sites
in collagen (17). When digesting the insoluble fiber, ColH is the workhorse (32). The higher
collagen affinity observed for s2b-s3 may increase further by the addition of s2a. The increased
affinity could hold ColH close to the collagen fibril so that it can slide along the fibril and find
vulnerable regions. Meanwhile, the proposed structure of holo-ColG adopts a compact structure
in which domains of the collagen-bonding segment are aligned by intermolecular β-sheet type
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hydrogen bond interactions (31). ColG’s tandem CBDs may allow the enzyme to anchor itself to
the most vulnerable region of the fibril. In this context, the spring-like dynamics of s2 may allow
it to swell the fibril. The swelled fibril would then expose the interior of the fibril and expose
new sites for ColH collagenolysis.
PKD evolution
Human PKD1 (1B4R (109)) and PKD-like domains from archaea and bacteria share a
high degree of structural similarity that suggests the fold laterally transferred across the
kingdoms. As expected, s2a, s2b, and s2 resemble the C. thermocellum endoglucanase PKD-like
domain (2C4X) more closely than either the archaeal surface protein PKD-like domain (1L0Q
(110)) or human PKD1. While the bulge between β-strands A and A’ appears to be well
conserved only in bacterial PKD-like domains, the bulge between β-strands B and B’ is also
conserved in the archaeal PKD-like domain, but is not conserved in PKD1. Correspondingly,
residues Thr800 and Asn825, which are critical for stabilizing this bulge, are conserved in the
archaeal PKD-like domain. Oddly, only Thr800 is conserved in the endoglucanase PKD-like
domain. Normally, surface interactions are not well conserved, but surprisingly, the salt bridge
formed between Asp816 and His828 in s2b is found in the archaeal PKD-like domain.
Structurally equivalent residues in the endoglucanase PKD-like domain, Asp47 and Tyr60,
utilize hydrogen bonding between OD1 and OD2 of Asp and OH of Tyr, in lieu of the salt
bridge. In the domains, these interactions serve to stack the β-sheets together and stabilize the
region where β-strand D of the Ig fold is deleted. The interaction is not found between the
equivalent Asp and His residues in the NMR structure of human PKD1, though it should be
noted that the NMR structure is derived from main-chain NOE restraints, and therefore the sidechain orientations are not experimentally obtained. Thus, these residues may also assist in the
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interaction of β-strands C and E. Within the core, Trp812 and Phe795 are conserved throughout
the three kingdoms. Our PKD-like domain structures suggest this Phe strengthen the interactions
of β-strands B and C through packing with the strictly conserved Trp and Phe in strand D. The
residue further supports the barrel architecture through hydrophobic packing with the C-terminal
region of the barrel.
Comparison of bacterial holo-PKD-like domains with either archaea or mammalian PKD
suggests that the Ca2+ binding site in bacteria evolved from archaea. In addition to the overall
structural similarity, five out of the seven oxygen atoms that coordinate to Ca2+ are present in the
archaeal PKD-like domain. The archaeal domain lacks the initial asparagine residue and one of
the axial aspartate residues required for Ca2+ binding. Ca2+ interacting residues Asn774 and
Lys775 of s2b are replaced by Pro302 and Val303 in archaea. In addition to removing an oxygen
atom responsible for the pentagonal base, Pro appears to constrain Val303_O to the position
occupied by Ca2+ (Fig. 8). The archeal PKD-like domain possesses the bidentate Asp802
equivalent. However, the loop is significantly shortened compared to the bacterial domains,
which consequently removes the Asp804 equivalent. It should be noted that water positioning
residues in s2b appear to be conserved in archaea (Ser845 is conserved, while Ser846 is replaced
with asparagine). The mammalian PKD meanwhile, lacks all residues that interact with Ca2+.
Comparison of clostridial PKD-like domain structures with V-set kappa light chain
Bence-Jones protein (1BRE (104)) as well as with archaea PKD-like domain and human PKD
suggests that the PKD1 domain fold in eukaryotes descended from the simpler Ig fold and then
may have spread to archaea. From archaea, the fold laterally spread to bacteria. Characteristics of
the V-set Ig fold that are shared with the PKD-like domain fold are: (1) The tertiary structure
consists of a two-faced β-sheet architecture made up from a well-packed hydrophobic core. (2)
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β-strand A is broken by a conserved bulge that changes the allegiance of the subsequent βstrands A’. (3) β-strand C contains the conserved tryptophan, and along with β-strand C’ (βstrand D of the PKD-like domain fold), forms a β-hairpin connected by an approximately ii+8
ω-loop. (4) The turn leading into β-strand F is stabilized by a Δ4 Tyr corner.
Conclusion
Comparison of the crystal structures of ColG s2 with the crystal structures of ColH s2a
and s2b, suggests that despite common tertiary folds, PKD-like domains could be grouped into
two subsets. The subset containing ColH derived domains exhibits exposed aromatic residues
and is found in M9B collagenases with a single CBD. The surface aromatic residues could be
involved in secondary interactions that allow weak collagen binding. In contrast, the subset
containing s2 is likely to be different; the lack of surface aromatic residues on s2 suggests that
the domain is less directly involved in interactions with collagen. Overall, this subset is found in
M9B collagenases with multiple CBDs. The unique differences in dynamics and surface
characteristics between s2a-s2b and s2 may aid in synergistic collagenolysis.
Meanwhile, the N-terminal linker structure of a PKD-like domain is described for the
first time in the holo-s2b structure, and suggests that Ca2+ repositions the linker along the barrel
axis. The helical structure of the linker upon Ca2+ binding may shorten the distance between s2b
and s2a, and may help account for the previously described proteinase resistance (81). Lastly,
our stability data show that the domains are extremely stable in the presence of physiological
Ca2+. Structural and stability data are critical for the development of PKD-like domains as part of
the site-directed delivery of signal molecules such as growth factors and cytokines.
Accession Codes
The full atomic coordinates of the PKD-like domains and their corresponding structure
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factor amplitudes have been deposited in the Protein Data Bank (PDB accession codes 4U6T,
4U7K, 4JGU, 4TN9, and 4JRW assigned to apo-s2a, holo-s2a, holo-s2b, and forms I and II of
apo-s2 respectively).
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Tables
Table 1: Data collection and refinement statistics.
Holo-s2a

Apo-s2a

Holo-s2b

Apo-s2 Form I

X-ray wavelength (Å)

1.54

1.54

0.97937

0.919

Space group

C2

P61

P21

P21

a (Å)

102.3

88.3

49.38

25.00

b (Å)

87.6

88.3

38.87

71.76

c (Å)

104.4

123.6

54.66

47.89

β (°)

116.0

90.0

98.43

95.56

γ (°)

90.0

120.0

90.00

90.00

Resolution (Å)

93.8-1.9

76.5-1.8

22.19-1.42

47.67-1.40

Highest resolution bin (Å)

1.98-1.91

1.81-1.76

1.44-1.42

1.44-1.40

Number of reflections

224,470

252,508

137,190

124,611

Redundancies (a)

3.6 (3.1)

4.7 (2.1)

3.5 (2.9)

3.3 (2.4)

Completeness (%) (a)

96.4 (93.8)

99.4 (95.7)

96.7 (85.8)

92.5 (83.7)

I/σI (a)

13.8 (3.0)

11.5 (2.3)

33.0 (3.1)

21.3 (2.0)

Rmeas (%) (a, b)

5.4 (31.0)

7.5 (37.4)

4.6 (38.5)

8.1 (46.9)

Data Collection
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Table 1 (cont.): Data collection and refinement statistics.
Holo-s2a

Apo-s2a

Holo-s2b

Apo-s2 Form I

Unique reflections

58,720

50,932

35,993

28,786

Rcryst (%) (a, c)

16.3 (25.5)

20.7 (26.8)

15.0 (25.4)

16.9 (28.3)

Rfree (%) 5% of data (a, d)

20.7 (29.7)

27.2 (32.0)

19.1 (33.2)

21.2 (35.6)

Average B-factor: Main chain A (Å2)

18.9

17.6

9.6

12.5

Average B-factor: Side chain A (Å2)

23.3

21.1

13.7

16.5

Average B-factor: Main chain B (Å2)

18.9

17.9

8.3

12.5

Average B-factor: Side chain B (Å2)

23.5

21.4

12.2

16.8

Average B-factor: Main chain C (Å2)

18.9

18.9

N/A

N/A

Average B-factor: Side chain C (Å2)

23.6

22.0

N/A

N/A

Average B-factor: Main chain D (Å2)

18.7

19.3

N/A

N/A

Average B-factor: Side chain D (Å2)

23.1

22.3

N/A

N/A

2

Average B-factor: Main chain E (Å )

19.0

N/A

N/A

N/A

Average B-factor: Side chain E (Å2)

23.5

N/A

N/A

N/A

2

Average B-factor: Main chain F (Å )

18.7

N/A

N/A

N/A

Average B-factor: Side chain F (Å2)

23.0

N/A

N/A

N/A

2

Average B-factor: Main chain G (Å )

18.8

N/A

N/A

N/A

Average B-factor: Side chain G (Å2)

23.1

N/A

N/A

N/A

2

Average B-factor: Main chain H (Å )

19.0

N/A

N/A

N/A

Average B-factor: Side chain H (Å2)

23.5

N/A

N/A

N/A

Average B-factor: Solvent (Å2)

46.1

42.2

25.6

31.1

Favored (%)

98.5

99.4

98.9

99.4

Additionally allowed (%)

1.5

0.6

1.1

0.6

Outliers (%)

0

0

0

0

Refinement

Ramachandran statistics

(a) Data for the highest resolution shell are given in parenthesis
𝑁ℎ

(b) Rmeas = ∑ℎ ∑𝑖 √𝑁

ℎ −1

|𝐼ℎ𝑖 − 〈Ih 〉|/ ∑h ∑i〈Ih 〉

(c) Rcryst = ∑ℎ𝑘𝑙||𝐹𝑜𝑏𝑠 | − |𝐹𝑐𝑎𝑙𝑐 || / ∑ℎ𝑘𝑙|𝐹𝑜𝑏𝑠 | for the 95% of reflection data used for
refinement.
(d) Rfree = ∑ℎ𝑘𝑙||𝐹𝑜𝑏𝑠 | − |𝐹𝑐𝑎𝑙𝑐 || / ∑ℎ𝑘𝑙|𝐹𝑜𝑏𝑠 | for the 5% of reflection data excluded from
refinement.
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Table 2: Ca-O bond distances and planar deviation for holo-s2b and holo-s2a.
s2b
Residue
Atom Distance (Å) Planar Deviation (Å)
Molecule A
HOH
O
2.49
0.09
N774
OD1
2.39
0.20
K775
O
2.41
0.27
D802
OD1
2.42
0.38
D802
OD2
2.44
0.22
D804: axial OD1
2.34
NA
D844: axial OD2
2.42
NA
Molecule B
HOH
O
2.40
0.14
N774
OD1
2.37
0.24
K775
O
2.38
0.28
D802
OD1
2.46
0.38
D802
OD2
2.49
0.19
D804: axial OD1
2.34
NA
D844: axial OD2
2.39
NA
s2a
Residue
Atom Distance (Å) Planar Deviation (Å)
HOH
O
2.53 (5)
0.03 (2)
N685
OD1
2.52 (6)
0.10 (3)
Average of
S686
O
2.43 (6)
0.14 (3)
Molecules
D713
OD1
2.51 (3)
0.15 (3)
A through
D713
OD2
2.50 (6)
0.09 (4)
H
D715:axial OD1
2.42 (3)
NA
754: axial
OD2
2.40 (5)
NA

74

Table 3: Stability paramaters for Gu.HCl denaturation of PKD-like domains.
holo-s2b apo-s2b holo-s2a apo-s2a holo-s2 apo-s2
-1
ΔG (kcal*mol )
9.8
6.9
7.8
4.9
6.0
4.3
-1
-1
m (kcal*mol *M )
3.1
2.6
3.6
3.1
2.4
2.7
CM (M)
3.2
2.6
2.2
1.6
2.5
1.6
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Figures

Figure 1: Domain map of collagenases ColG and ColH from Clostridium histolyticum. The
prepro-peptide (gray dashes) is cleaved from the mature enzyme and indicated by sequence
numbering N1-N110 (ColG) and N1-N40 (ColH). The collagenase module is composed of an
activator subdomain (olive) and peptidase subdomain (dark olive) that is accompanied by a
helper subdomain. The PKD-like domain(s) (yellow for ColG; cyan and green for ColH) connect
the collagenase module to the C-terminal CBD(s) (red for ColG; salmon for ColH) that are
responsible for collagen-binding.
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Figure 2: Structural comparison of holo-s2a (A), apo-s2a (B), holo-s2b (C), and apo-s2 (D).
Hydrogen bonds and sharp turns that stabilize β-bulges are highlighted.
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Figure 3: Structure based sequence alignment of PKD-like domains from M9B. Residues
responsible for Ca2+ binding, for positioning the Ca2+ interacting water, architecturally critical
residues, and surface aromatic residues are shown in red, orange, green and blue, respectively.
Sequence numbering and secondary structure position for s2b is shown at the top of the figure.
Secondary structure position for the s2 structure is similar, though the 310 helix is absent.
Sequence numbering for s2a and s2, as well as secondary structure position for s2a is shown at
the bottom of the figure. Sequence alignment was aided by the use of ClustalW2 (79).
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Figure 4: Ca2+ coordination in s2a (A) and s2b (B). Seven oxygen atoms from five residues and
one water molecule coordinate with Ca2+ in a pentagonal bipyramidal geometry. Pentagonal base
interactions are indicated using brown dashes, while axial interactions are indicated using yellow
dashes. Residue to water interactions are indicated with blue dashes. Either one aspartate (s2a) or
adjacent serines (s2b) are responsible for positioning the water molecule along the pentagonal
base.
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Figure 5: Cα B-factor changes upon Ca2+ binding for s2a (A) and s2 (C). Cα B-factor of holo-s2b
(B) is also shown.
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Figure 6: Results of fluorescence-measured equilibrium denaturation of (A, D) s2a, (B, E) s2b,
and (C, F) s2 in their apo-(open circles) and holo-forms (closed circles).
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Figure 7: Surface aromatic residues in s2a (A) and s2b (B). The boxed in regions corrspond to
residues Ala766-Asp770, which is observed in both s2a and s2b structures and was used to help
assemble the full holo-ColH structure (C). This structure is assembled from the crystal structures
of the peptidase domain of s1, s2a , s2b , and s3, as well as the homology modeled activator
domain of s1. Homology modeling was accomplished using SWISS-MODEL (111). Surface
exposed aromatic residues of the peptidase domain of s1 and s2a-s2b as well as the conserved
collagen interacting aromatic residues of s3 are shown in yellow. Ca2+ is shown as orange
spheres.
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Figure 8: Proposed evolution of the Ca2+ binding pocket in bacterial PKD-like domains (holos2b shown on the left) from the archaea PKD-like domain (1LOQ shown on the right).
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Supplemental Material
Tables
Supplemental table 1: Data collection and refinement statistics.
apo-s2 Form I
Data Collection
X-ray wavelength (Å)
Space group
a (Å), b (Å), c (Å)

0.919
P212121
45.0, 49.0, 70.9

β (°)

90.0

γ (°)

90.0

Resolution (Å)

40.3-1.6

Highest resolution bin (Å)

1.64-1.60

Number of reflections

165,013

Redundancies (a)

4.1 (3.6)

Completeness (%) (a)

99.9 (99.6)

I/σI (a)

30.9 (2.1)

Rmeas (%) (a, b)

7.0 (69.2)
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Supplemental table 1 (Cont.): Data collection and refinement statistics.
apo-s2 Form I
Refinement
Unique reflections

20,159

Rcryst (%) (a, c)

16.2 (26.5)

Rfree (%) 5% of data (a, d)

19.2 (30.6)

Average B-factor: Main chain A (Å2)

11.2

Average B-factor: Side chain A (Å2)

15.7

Average B-factor: Main chain B (Å2)

11.6

Average B-factor: Side chain B (Å2)

16.2

Average B-factor: Solvent (Å2)

28.1

Ramachandran statistics
Favored (%)

100

Additionally allowed (%)

0

Outliers (%)

0

(a) Data for the highest resolution shell are given in parenthesis
𝑁ℎ

(b) Rmeas = ∑ℎ ∑𝑖 √𝑁

ℎ −1

|𝐼ℎ𝑖 − 〈Ih 〉|/ ∑h ∑i〈Ih 〉

(c) Rcryst = ∑ℎ𝑘𝑙||𝐹𝑜𝑏𝑠 | − |𝐹𝑐𝑎𝑙𝑐 || / ∑ℎ𝑘𝑙|𝐹𝑜𝑏𝑠 | for the 95% of reflection data used for
refinement.
(d) Rfree = ∑ℎ𝑘𝑙||𝐹𝑜𝑏𝑠 | − |𝐹𝑐𝑎𝑙𝑐 || / ∑ℎ𝑘𝑙|𝐹𝑜𝑏𝑠 | for the 5% of reflection data excluded from
refinement.
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Supplemental table 2: Alternate conformations of the PKD-like domains
Domain
Molecule
Alternate conformations
Apo-s2a
Molecule A
S720, K742, and S762
Molecule B
D715 and K742
Molecule C
K697, S720, and N732
Molecule D
D715, S720, and N732
Holo-s2a
Molecule A
S686, S759, and T763
Molecule B
S720 and S759
Molecule C
None
Molecule D
S762
Molecule E
S686 and S762
Molecule F
S759 and S762
Molecule G
S686 and S759
Molecule H
S686 and S762
K792, V793, S806, S822, S827, and
Holo-s2b
Molecule A
M854
Molecule B
S786, S806, S822, and S827
R702, K717, R732, S736, T761, and
Apo-s2 Form I
Molecule A
S763
I689, K691, S720, T730, T749, and
Molecule B
T761
Apo-s2 Form
Molecule A
E714, N747, T749, and T761
II
Molecule B
K691, E714, V737, and S763
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Supplemental table 3: hydrogen bond totals for PKD-like domains in presence and absence of
Ca2+.
Domain
Molecule
NH…O OH…O NH…N CH…O total
Apo-s2a
Molecule A
45
8
19
95
167
Molecule B
38
8
19
87
152
Molecule C
37
7
18
93
155
Molecule D
39
8
20
92
159
Holo-s2a Molecule A
45
7
18
86
156
Molecule B
43
6
18
90
157
Molecule C
42
7
19
91
159
Molecule D
46
6
18
88
158
Molecule E
47
6
18
86
157
Molecule F
41
7
18
95
161
Molecule G
40
6
18
89
153
Molecule H
40
7
18
84
149
Holo-s2b Molecule A
45
12
20
73
150
Molecule B
47
6
20
85
158
Apo-s2
Molecule A
46
5
18
77
146
Molecule B
48
4
18
82
152
Holo-s2
Molecule A
45
6
17
70
138
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Figures

Supplemental figure 1: HSQC spectra for uniformly 15N labeled s2. In the spectra, thirteen
residues could not be identified due to extensive band broadening.
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Supplemental figure 2: Ca2+-induced structure rearraingment in the PKD-like domains. The Nterminal loop of s2a (A) is re-oriented as indicated by the rotation along the ψ bond of Asn685.
The N-terminal linker of s2b (B) is observed in the crystal structure and indicates that the linker
forms a 310 helix (hydrogen bonding indicated by red dashes). Unlike s2a and s2b, the loop (713717) of s2 (C) moves out to accommodate Ca2+.
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Supplemental figure 3: Per-residue B-factor trend for the PKD-like domains. The trends for holos2a (A), apo-s2a (B), holo-s2b (C), and apo-s2 (D) are similar. Comparison of the averaged Bfactor of apo-s2 with holo-s2 (E) revealed the distinctly different influence Ca2+ has on potential
dynamics.
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Chapter 4: Activation and binding mechanism of a clostridial tandem collagen-binding
domain with pseudo-two-fold symmetry
Abstract
Clostridium histoliticum secrets virulence factors, including highly active collagenases CollG
(class I) and ColH (class II), which penetrate animal tissues. After the multi-domain ColG
utilizes its tandem collagen-binding domain (CBD) to anchor itself onto insoluble collagen,
subsequent degradation of the hierarchical substrate involves processive cleavage and
rearrangement of fibrils. In this work, the structure of the calcium bound tandem CBD is
presented at 1.9 Å resolution (Rwork = 15.0%; Rfree = 19.6%). The pseudo-two-fold arrangement
of CBD could allow ColG to wedge between collagen molecules that are 55 Å apart and
subsequently aid in fibril rearrangement and processive cleavage. Indeed, between 0.1:1 and
0.5:1 molar ratios of tandem CBD and collagen, it accelerated collagen fiber formation. At 1:1
molar ratios and above, the tandem CBD retarded fibril formation. To toggle between collagen
molecules, a tighter binding C-side CBD, may initiate binding. Subsequently, the weaker binding
N-side CBD can latch onto a prone collagen molecule to provide the tightest known fibril
binding. The conformational change of the tandem CBD is calcium dependent and cooperative as
measured by size exclusion chromatography and by SAXS at pCa in the range of 3-6. At pCa >
5, the tandem CBD adopts an extended structure that is easier to be secreted from the bacterium.
In the host pCa2+ >3, the compact structure seen in the crystal structure is adopted. The binding
and activation mode described here will help guide site-directed drug delivery vehicle
development.
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Introduction
Fibrous collagen is resistant to most proteases due to its tightly packed structure, which
shields the peptide bonds. Most clostridial collagenases possess multiple collagen-binding
domains (CBD) (Supplementary Fig. 1). The evolutionary advantage for this redundancy is
addressed by determining the structure of the tandem CBD segment of collagenase ColG from
Clostridium histolyticum. The catalytic domain alone is capable of hydrolyzing solubilized
collagen while C-terminal CBDs of ColG (s3a, s3b) are necessary for dismantling collagen fibril
(29, 31).
The C-terminal collagen-binding domains (CBDs) of ColG (s3a, s3b), and ColH (s3), are
homologs consisting of approximately 120 amino acids. The domains bind to soluble and
insoluble collagen structures. Their role in binding to collagen fibril is essential in dismantling its
hierarchical structure (40, 43). Truncation of CBD from either full-length ColG or ColH
incapacitates their abilities to degrade collagen fibril. Such enzymes can only degrade solubilized
collagen or denatured collagen (gelatin). Mutagenesis and collagen-binding studies mapped the
binding surface of s3b, while NMR and SAXS studies showed that s3b unidirectionally binds to
under-twisted regions of mini-collagen (45, 66). High-speed atomic force microscopy has
recently revealed ColG’s ability to dismantle collagen in real time (33). During degradation,
ColG moves processively from the fibril’s C-terminus to its N-terminus to dismantle the fibril.
ColG also initially targeted less ordered regions of the fibril.
Bacterial collagenases require calcium to attain both full catalytic activity and collagenbinding function. The activation of bacterial collagenase involves domain rearrangement
triggered by the Ca2+ binding (29, 30, 64, 80, 112). The full-length ColG is expected to be
relatively flexible inside the bacteria where Ca2+ concentration is low (0.2-0.3x10-6 M) allowing
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the enzyme to be secreted easier (29). Upon secretion, the linker chelates to Ca2+ (~1.2 mM) in
the ECM to adopt a rigid structure. Though it has not been shown for ColG, Ca2+ chelation
indeed triggers full-length ColH to adopt a compact, less flexible structure (81).
The clostridial collagenases have been successfully used for years as a wound
debridement. Recently the mixture of ColG and ColH was approved for use in the treatment of
excessive connective tissue build up found, for example, in Dupuytren's disease (113). In
addition to therapeutic use of full-length collagenase for removal of connective tissue, the noncatalytic segments are used for targeted drug-delivery to reduce dosage and to minimize side
effects. Initially, Nishi et al. developed fusion proteins of s2b-s3 and growth factors. When
injected, the fusion proteins remained active at the site of injection for up to 10 days (46). While
systemic applications utilize fusion proteins consisting of lower affinity collagen-binders (e.g.
s3) to treat osteoporosis (48-50), and to prevent and to treat alopecia (47, 96, 114, 115), tighter
collagen-binders (e.g. s2b-s3) are more efficacious in localized wound healing applications when
applied at the site of injury with collagen-based bone graft material (116-118). Since tandem
CBD bind to collagen even tighter than s2b-s3 (43), these results suggest a clinical significance
for tandem CBD.
Methods
Production, Purification, Crystallization and Structure Determination
Individual s3a, s3b, as well as tandem CBD derived from the C. histolyticum ColG were
expressed as glutathione S-transferase (GST)-fusion proteins using method as described
previously (40). Initial conditions suitable to grow crystals of tandem CBD were identified by
high-throughput screen (Hampton Research Crystal Screen HT). Subsequent crystallization trials
using the initial conditions were carried out using the hanging-drop method. Crystals of tandem
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CBD, obtained in the presence of 21-26% PEG 3350, 0.1 M HEPES pH 7.5, 3 mM calcium
chloride, were orthorhombic (space group, P212121), with cell parameters a = 51.5 Å, b = 54.7 Å,
c = 92.0 Å. The crystals grew within 24 hours in 37°C but did not grow at lower temperatures.
The crystals were temperature sensitive and could not withstand cryogenic temperatures.
Therefore, diffraction data were collected by means of in–house X-ray facility at room
temperature to 1.9 Å resolution using a Rigaku 007 generator with Cu Kα radiation. The data
sets were processed with d*TREK (99) (Supplementary Table 1). The structure was solved with
the molecular replacement program MolRep from the CCP4 package, by using s3b (PDB code
2O8O) as the search model (52). One tandem CBD was found in an asymmetric unit; and
therefore, VM was 2.5 Å3/Da and solvent content was 50% (119). Refinement of the tandem
CBD was carried out using Refmac_6.1.13 (52). TLS restraints were applied to main chain
atoms with each CBD acting as a TLS group. Babinet scaling was used for bulk solvent
refinement. Five percent of the data were set aside to monitor Rfree. The models were manually
adjusted between each refinement cycle using MIFit (55). Alternate confirmations were built for
Lys818, Glu945, Tyr970, and Arg1005. The Ramachandran plot for the final structure obtained
with the RCSB validation server (120) showed 91% of the residues in the core region and 9% in
the additionally allowed region, with none in the generously allowed or disallowed regions. The
final refinement statistics are shown in Table 1.
Small Angle X-ray Scattering
Suitable buffer conditions for small angle X-ray scattering (SAXS) measurements were
identified using Native-PAGE. For the pCa (-log [Ca2+]) analysis the tandem CBD was initially
equilibrated into 100 mM NaCl and 2% glycerol. Measured quantity of CaCl2 and 0.2 mM total
EGTA achieved pCa values to 3, 4, 5 and 6. The amount of Ca2+ needed to reach a given pCa
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was determined using MAXCHELATOR (121). Measurements were completed for three
concentration series per sample. For the pCa series, the concentration of tandem CBD used at
pCa 4 and 5 and 6 was 1, 3, and 5 mg/mL. At pCa 3, the concentration series used was 2, 4, and
6 mg/mL. All SAXS data were collected at 10°C at the Advanced Light Source at Berkley
National Lab (SIBYLS beamline, 12.3.1) (122, 123) using a Pilatus 2M detector. Sample to
detector distance was 1.5 m, and X-ray wavelength was 1.127 Å. All data processing was
accomplished using primusqt from the ATAS 2.6.1 software package. For CBD at each pCa and
the complex with mini-collagen, exposure data from the concentration gradient that were not
affected by either aggregation or detector saturation were extrapolated to infinite dilution.
Determination of the radius of gyration (Rg), maximum diameter (Dmax) as well as ab initio shape
reconstruction of the extrapolated data for each model in the pCa series was carried out using the
dammif function in primusqt. The χ values calculated at the end of each run indicated the
agreement between the calculated scattering curve and the experimental scattering curve. The Rg,
Dmax, and χ values for each model are summarized in Table 2.
Collagen Fibril Formation
The impact of addition of tandem CBD, S3a and S3b on self-assembly of collagen
molecules was monitored by measuring turbidity as an increase in optical density at 450 nm, at
37ºC (Supplementary Fig. 2). On ice, a solution of 2 mg/ml of rat collagen was diluted with 40
mM HEPES buffer pH 7.5, with addition of 300 mM NaCl, 2 mM CaCl2, to final concentration
of 0.5 mg/ml (2.4 µM). In the next step collagen binding domain was added in ratios: 0.1 to 1;
0.2 to 1; 0.3:1; 0.5 to 1; 1 to 1; 2 to 1; 3 to 1; 5 to 1 of molar concentration. The turbidity
measurement was taken in 96 well plates with 1-minute intervals with spectrophotometer Filter
Max F5 (Molecular Devices). From the turbidity curve the following parameters were estimated
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tlag-time at the end of lag phase, maximum turbidity, and V the maximum fibril growth rate
(Supplementary Table 1). Retardation of collagen fibril formation by s3b (C-side CBD) was as
expected (124).
Analytical Size Exclusion Chromatography
Size exclusion chromatography was performed at room temperature on a HPLC system
equipped with a Superdex 75 column (1 × 30 cm, Pharmacia) at a flow rate of 0.5 ml/min as
described (29). The following proteins were used as molecular mass standards: bovine serum
albumin, 67.0 kDa; chicken ovalbumin, 43.0 kDa; and ribonuclease A, 13.7 kDa (Pharmacia).
The measurement was carried out in triplicate. For every apparent mass measured for the tandem
CBD at different pCa, standard deviation was less than 0.06 kDa.
Results and Discussion
Structural description of tandem CBD
The crystal structure of tandem CBD consists of s3a, which is described for the first time
in this paper, and the previously described s3b (29). Both s3a and s3b adopt similar β-sandwich
‘jelly-roll’ folds composed of ten β-strands. The CBDs are related by a pseudo two-fold
rotational symmetry that is stabilized by salt-bridges and hydrogen-bonding interactions. The
pseudo symmetry axis, which is perpendicular to the plane of the page in Fig. 1a, positions the
collagen-binding pockets in the tandem CBD to be ~55 Å apart. Each domain chelates to two
Ca2+ as described (29, 80). Overlay of 110 equivalent Cα atoms showed that s3a and s3b share a
root mean square deviation (r.m.s.d.) of 0.9Å and most significantly deviate at loops with
r.m.s.d. of approximately 2.5 Å.
Influence of Ca2+ on domain rearrangement
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Calcium ions are thought to trigger domain rearrangement that can enhance ColG’s
efficiency in digesting fibril. The domain rearrangement of tandem CBD triggered by Ca2+
binding is examined here. Hydrodynamic radius change monitored by size exclusion
chromatography demonstrated that Ca2+-induced domain rearrangement is cooperative.
Molecular shape transformation was visualized by small angle X-ray scattering (SAXS, Fig.1b).
The SAXS derived envelope for tandem CBD at pCa 6 (1 µM) adopts an elongated, rod-like
shape. The protrusion from the envelope resembles the α-helical linker from the molecular
envelope of apo-s3b (64). Increasing Ca2+ concentration compacts the tandem CBD. At pCa 4
(100 µM) the shape resembles the crystal structure with the exception of a bulge that suggests
the N-terminal linker remained dynamic. At pCa 3 (1 mM) the shape agrees well with the crystal
structure. The difference in Ca2+ concentration inside Clostridium, which is likely similar to the
concentration inside Escherichia coli (0.2–0.3 × 10–6 M; pCa~7)(125), and host ECM (~1.2 mM;
pCa~3) (126) could be exploited by the bacteria to facilitate rapid secretion into the host.
Unique influence of tandem CBD on collagen fibril formation
Previously, s3b was shown to bind collagen unidirectionally (45). The pseudo-two-fold
arrangement of tandem CBD would allow the domain to bind to two parallelly oriented
tropocollagen molecules. Individually, s3a or s3b, retards collagen fibril self-assembly
(Supplementary Fig. 2) similar to other collagen-binders (124). However, since tandem CBD
could facilitate aligning collagen molecules, we tested its potential to promote fibril selfassembly by monitoring the turbidity of mixtures of tandem CBD and collagen at 450 nm (Fig.
2a). Here, we observed the first instance where a collagen-binder accelerates fibril formation. In
the absence of tandem CBD (control), the lag time for fibril formation is 19 min as previously
observed (124). The lag time progressively shortens as tandem CBD concentration increases
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from 0.1:1 (tandem CBD:collagen) to 0.5:1. At a 0.5:1 ratio of tandem CBD to collagen, the lag
time is reduced to 15 min. At low concentrations, tandem CBD indeed aids in collagen fibril selfassembly. As concentration of tandem CBD increases, the lag time also correspondingly
increases. At a tandem CBD to collagen ratio of 5:1, the lag time is 30 min. The dual role of the
tandem CBD on collagen fibril assembly may provide an important clue to understand how fulllength ColG dismantles insoluble fibril. High-speed atomic force microscopy visualized ColG’s
processive movement and its rearrangement of collagen fibrils (33). ColG initiates collagenolysis
from disordered regions. Here, the tandem CBD’s role is to intercalate into the niche provided in
the disordered region and to anchor the collagenase onto the fibril. The subsequent C-terminus to
N-terminus processive cleavage could then be facilitated by tandem CBD correctly positioning
the catalytic domain. ColG also isolates collagen fibrils and rearranges them to thicken
neighboring fibrils. The tandem CBD’s ability to facilitate collagen fibril formation may allow
ColG to rearrange collagen fibril.
Collagen-binding mode
The opposing positions of the collagen-binding clefts on tandem CBD present unique
modes for the domain to latch onto collagen fibril. Whereas collagen fibril is built from a
staggered array of triple-helical tropocollagen, and is water insoluble, synthetic mini-collagen,
which mimics the tropocollagen structure, is water soluble and also allows solution-based
analysis of CBD-collagen interaction. Measured dissociation constants for the interaction
between the CBDs and either mini-collagen or fibril tend to agree (43). Tandem CBD is the
tightest binder to collagen fibril, and is able to bind tighter than the sum of s3a and s3b
individually. However tandem CBD binds mini-collagen about as tightly as s3b alone (43).
Corroborating this, the SAXS-derived shape of the CBD:mini-collagen suggests only one CBD
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bound to mini-collagen, even when two-fold excess of mini-collagen was used (Supplementary
Table 2). The binding affinities of s3a and s3b to mini-collagen suggest s3b initiates collagen
binding. Furthermore, the sequence alignment of multiple CBD binding segments suggests this
binding strategy is conserved amongst the collagenases possessing tandem CBDs. The three
most critical tyrosine residues for collagen-binding in s3b (970, 994, and 996) are conserved
amongst C-side CBDs, while only tyrosine residues 970 and 994 are conserved amongst N-side
CBDs (Supplementary Fig. 1b). Apparently, gene duplication of CBD required reduced
functionality in the N-side CBD in order to prevent tandem CBD from binding too tightly to
collagen fibril. The tighter binding s3b initiates binding and serves the central role, while s3a
plays an auxiliary, yet pivotal role in intercalating between collagen molecules in collagen fibril.
The 5.5 nm spacing of binding clefts in tandem CBD excludes the segment from reaching
tropocollagen molecules within tightly packed hierarchical arrangements. However, the spacing
would allow it to seek either interfibrous spaces or crevices on the surface of damaged collagen
fibril (Fig. 2b). The median surface-to-surface distance between fibers in normal skin is only
~3.2 nm. However, the interfibrous space widens to ~6 nm in regenerating skin (127).
Meanwhile loss of two micro-fibrils from the surface of fibril could also generate an ~6 nm gap
(33). Bacterial collagenase equipped with tandem CBD could initiate destruction from these
most vulnerable regions.
Application of tandem CBD to localized drug delivery
The binding segments can converge fused growth factors to the site of lesion, which
minimizes dosage and side effects in rodents (46, 116-118). The fusion protein of basic FGF and
tandem CBD yielded the highest efficacy in healing bone fracture (128). Our results present the
structural support for use of tandem CBD in localized therapeutic delivery.
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Accession codes
The full atomic coordinates of the tandem CBD and its corresponding structure factor
amplitudes have been deposited in the Protein Data Bank (PDB accession code 5IKU). SAXS
data and corresponding ab initio models have been submitted to the Small Angle Scattering
Biological Data Bank (SASBDB accession codes CL2, CM2, CN2, CP2 assigned to envelopes
for tandem CBD at pCa 3, 4, 5, and 6 respectively).
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Tables
Table 1. Data collection and refinement statistics
Data collection statistic
Wavelength (Å)
Temperature (K)
Resolution range (Å)a
Space group

1.5419
298
19.7-1.90 (1.97-1.90)
P21 21 21

Unit cell dimension (Å)
a (Å)
b (Å)
c (Å)
Unit cell angle (°)
Total reflections
Redundancy
Completeness (%)a

51.5
54.7
92.0
α, β, γ = 90
89,473
4.47 (4.27)
94.8 (94.2)

Rmeas (%)a, b

7.1 (49.2)

I/σI

11.2 (2.9)

b
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Table 1 (Cont.): Data collection and refinement statistics
Refinement statistic
Unique reflections
Solvent molecules
Rwork (%)

18,987
211
15.0 (25.5)

Rfree (%)b, c

19.6 (26.8)
2

Average B value (Å )

37.68

Coordinates ESU based on Rfree (Å)

0.13

Root mean square deviations
Bond distance (Å)
Bond angles (°)
Chiral centers (Å3)
Planar groups (Å)
B-factor restrains
Main - chain bond (Å2)

0.011
1.87
0.17
0.01

Main-chain angle (Å2)

4.72

2

3.81

Side- chain bond (Å )

6.84

Long range B-factor (Å2)

12.3

Ramachandran statistic
Most favored region (%)
90.9
Allowed region (%)
9.1
a
Rmeas = hkl (N(hkl)/N(hkl)-1)1/2 iIi(hkl) -I(hkl)  (hkl)iIi(hkl)
b
c

Data for highest resolution shell are given in parentheses
5% of data excluded from refinement
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Table 2: Small Angle X-ray Scattering Statistics for the tandem CBD at different pCa.
pCa
3.0
4.0
5.0
6.0

Rg (Å)
24
25
25
27

Dmax (Å)
75
76
94
128

χ
0.8
1.0
0.8
1.2
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Figures

Fig 1. Crystal structure of tandem CBD and Ca2+ induced transformation. (a) The N-side CBD
(s3a) and the C-side (s3b) are drawn in green and orange, respectively. Four Ca2+ (red) are
chelated by the CBDs. Aromatic residues (blue) were previously identified to interact with minicollagen (29, 45). (b) Size exclusion chromatography and SAXS experiments were carried out in
HBS-based calcium buffers of varying pCa.
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Fig 2. Putative binding mechanism for tandem CBD. (a) Promotion (red) and retardation (blue)
of collagen fibril formation by tandem CBD. (b) Schematic drawing of putative collagen niches
preferred by tandem CBD.
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Supplemental material
Table
Supplementary Table 1: Turbidity parameters of self-assembly of collagen in a presence of
collagen binding domain
Tandem CBD to collagen molar ratios
collagen 0.1:1 0.2:1 0.3:1 0.5:1 1:1
2:1
3:1
5:1
tlag (min)
19.0
19.0
18.0
17.0
15.0
21.0
24.0
27.0
30.0
V
0.019
0.022 0.022 0.021 0.019 0.017 0.014 0.010 0.005
(turbidity/min)
ΔA (turbidity) 0.284
0.266 0.271 0.277 0.268 0.274 0.287 0.291 0.331

collagen
tlag (min)
11.6
Vmax
0.014
(turbidity/min)
ΔA (turbidity) 0.256

collagen
19.9
0.041

tlag (min)
Vmax
(turbidity/min)
ΔA (turbidity) 0.289

s3a to collagen molar ratios
0.1:1 0.2:1 0.3:1 0.5:1
15.3
13.6
15.9
11.2
0.027 0.013 0.014 0.016

1:1
17.0
0.024

2:1
19.0
0.016

3:1
21.6
0.022

5:1
15.6
0.011

0.336

0.249

0.270

0.276

0.272

0.293

s3b to collagen molar ratios
0.1:1 0.2:1 0.3:1 0.5:1
20.3
20.6
20.4 20.5
0.035 0.034 0.033 0.030

1:1
25.1
0.027

2:1
32.9
0.018

3:1
42.6
0.013

5:1
68.3
0.008

0.281

0.289

0.314

0.337

0.341

0.282

0.283

0.246

0.278 0.264
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Figures

Supplementary Fig. 1 (a) Phylogenic tree of M9B collagenases (InterPro 002169). (b) Sequence
alignment of tandem collagen binding domains in M9B collagenases from Clostridium
sporogenes, C. botulinum A3, C. perfringens, Bacillus. brevis, Paenibacillus dendritiformis, C.
sordellii and C. histolyticum. N-side CBD molecules are aligned on the top rows, and C-side
CBDs are aligned on the bottom rows. Calcium-binding residues (chelator in red and spotter of
chelator in orange), structurally important residues (green) are conserved. Based on biophysical
studies completed for s3b (29_ENREF_29, 45, 66), residues that conjectured to interact with
mini-collagen are highlighted in blue. One of the most well conserved and critical residues for
collagen interaction in s3b is Tyr996. Tyr996 equivalent is conserved in the C-side CBD but not
in the N-side CBD.
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Supplementary Fig. 2 (a) Retardation of collagen fibril formation by s3a (N-side CBD). (b)
Retardation of collagen fibril formation by s3b (C-side CBD).
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Chapter 5: Conclusion
The crystal structures of Ca2+-bound s2a, s2b, s3, s3a-s3b and Ca2+-absent s2a and s2
facilitate understanding of the division of labor utilized by collagenases ColG and ColH to
degrade collagen. Over time, evolutionary pressure appears to have tuned the role of homologous
domains to maintain Ca2+-triggered activation, yet also initially recognize unique regions on
collagen. Initiating collagen degradation at unique regions would allow the collagenases to
synergistically work towards collagen dismantling. The novel crystal structure of the Ca2+-bound
(holo)-s3 closely resembles the higher resolution, re-refined structure of holo-s3b, and shares
both Ca2+-induced stabilization as well as the architecture of the collagen-binding cleft.
However, charge differences on the surface of the collagen-binding cleft may allow the domains
to initiate binding at different regions. The PKD-like domain s2b is not a collagen-binder, but it
has been shown to tighten the interaction between s3 and collagen. Curiously, the role of s2b as a
source of secondary, weak interaction that improves binding to collagen is analogous to the role
of s3a. While s3a is a CBD, its collagen-binding cleft lacks a key tyrosine found in s3b. Both s2b
and s3a allow the main CBD to bind tighter, but not become locked into a single site. The
tandem CBD structure represents the first structure of two domains from collagenase. With this
structure, the Ca2+-induced domain rearrangement could be evaluated using SAXS. The
molecular envelopes obtained using this technique indicate the domain transforms from an
elongated, flexible confirmation to the compact, pseudo-two-fold arrangement seen in the crystal
structure. In correlation with SAXS studies of ColH, the domains of the apo-collagenase inside
the bacterium appear to be connected by flexible linkers that can facilitate secretion from the cell
into the host extracellular matrix. Here, the enzyme must resist proteases secreted by the host
immune system. The domains therefore likely utilize the higher Ca2+ concentrations of the
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extracellular matrix to trigger domain rearrangement into the compact holo-enzyme, which is
expected to minimize protease targets.
Development of applications of the targeting segments of ColG and ColH are aided by
structural and functional studies that identify the role of targeting segment domains. Systemic
delivery of a therapeutic, for example, in the treatment of ostroporosis could benefit from use of
collagen-binders that do not bind ultra-tight to collagen. Localized delivery, which would be
used in the treatment of ailments such as bone fracture, necessitates minimal collagen-binder
distribution. The work described in this dissertation indicates that CBD, PKD-CBD, and tandem
CBD are extremely stable proteins that are capable of withstanding in vivo conditions. Moreover,
these domains are likely to target the damaged regions of collagen that are induced by the
ailment. Selection of collagen-binding segment for the therapeutic delivery can be guided by
binding affinity of the segment.
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